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1 Abstract 
Today, 1-2.5% of all genitourinary tract trauma affect the ureters, leading to severe 
impairments of the urine’s drainage. Till now, classical reconstructive surgery has 
the possibility to bridge up to 15 cm of damaged tissue, depending on the location. 
Even the “gold standard”, with intestine interposition, where longer distances can 
be overcome, can lead to postoperative side effects like stricture formation, 
calcification or excessive mucous production. 
This thesis presents a new attempt for the replacement of damaged ureters by the 
use of tissue engineering technologies. A bioreactor system is developed for the 
generation of tubular biohybrids consisting of a natural and a composite 
biomaterial (pure collagen or fibrin and PVDF) in combination with different cell 
types (Urotsa, C2C12, fibroblasts and primary smooth muscle cells). A 
mechanotransduction is established for a mechanical stimulation and orientation of 
the applied cells. 
The bioreactor system allows a reliable incubation of a modularly constructed 
bioreactor for the cultivation of mammalian cells for up to two weeks. Incubation 
parameters are kept in defined ranges with deviations of ≤1 °C (temperature), 
≤0.2 (pH value) and ≤0.3% (CO2 concentration). Cocultivations of Urotsa and 
C2C12 cells are possible in combination with a porous OPTIMAIX 3D, which has 
radially oriented pores with varying diameters. Mechanical stimulation that is 
based on a kyphoplasty catheter is applied on primary smooth muscle cells that 
are embedded in a PVDF-supported fibrin matrix. Biochemical and mechanical 
evaluations reveal that there is no significant difference between a mechanically 
stimulated and an unstimulated prosthesis with respect to the diffusion of 
urea/creatinine or the rupture pressure. Histological analysis shows two 
distinguishable cell layers with a longitudinal alignment on the outer surface and a 
circular orientation in the matrix of the stimulated fibrin-based prosthesis. 
It can be concluded that biohybrids can be generated in this bioreactor system 
with at least two different cellular orientations. These biohybrids need to be 
characterised in further (animal) experiments. 
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2 Introduction 
Life expectancy is constantly increasing in modern, industrial countries like 
Germany, France, Spain, Japan or the USA. The rise in the last 40 years is in the 
range of 5 to 10 years, depending on the country and sex.[1] It has to be 
concluded, that factors like social, political and economical changes, as well as 
biomedical developments lead to people living longer than only decades ago.[1] 
This, in turn, often results in multimorbid patients i.e. people developing more than 
one chronic disease. This trend requires individual, personalised medical care.[2] 
Furthermore, it can be observed that the demand for organ transplants cannot be 
satisfied adequately. In 2012, 6337 patients were registered on German waiting 
lists for organ transplantations, while 1024 persons were listed as donors. The 
total demand for organ transplants was 6711 whereas 2625 organs were 
transplanted.[3] Figure 1 shows an illustration of deceased organ donors in 
Germany from 1998 to 2013. 
 
Figure 1: Progression of post mortal organ donators from 1998-2013 in Germany. 
Data investigated by the German Organ Transplantation Foundation and 
„statista“.[4–6] 
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This figure illustrates that there was a dramatic decrease in donors between 2011 
and 2013. The lack of donor organs got worse due to scandals caused by 
manipulated waiting lists. 
In regenerative medicine, the developing scientific field of tissue engineering (TE) 
may help counteract this lack. Tissue Engineering is a modern, multidisciplinary 
field of engineering sciences and medicine. Its purpose is to understand organ 
function in general and devise methods to grow functionalised organs that 
maintain or enhance.[7,8] 
Biologists, physicians, engineers, material scientists and many more work on this 
interdisciplinary perspective. It is necessary to consider all demands on an organ’s 
function and its generation to be successful in TE.[9–11] 
The engineering part includes the development of devices and (bio) materials, for 
tissue cultivation and functionalisation. All materials, including bioreactor 
components and liquids, that are in contact with the tissue equivalent need to 
mimic nature. Tissue Engineering has to be biomimetic.[12] 
The aim of this study was to develop a bioreactor system with the ability to 
functionalize biohybrids that may serve as tissue equivalents for the replacement 
of damaged tubular organs of the genitourinary tract, especially the ureters. To 
achieve this, a first bioreactor prototype had to be further developed, cell culture 
technologies had to be refined, a peristaltic stimulation procedure had to be 
established and a suitable biohybrids composition had to found. 
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3 Background 
3.1 The genitourinary tract 
The genitourinary tract is a central group of organs, keeping the biochemical 
balance, producing signal molecules, excreting metabolic wastes and controlling 
the body’s water household.[13,14] 
Figure 2 gives an overview of the revulsive organ network, disregarding sex 
specific genitalia. On the left side of the figure, each organ is symbolised by 
mechanical components in order to illustrate its function in a simplified manner and 
convey an engineer’s point of view. 
 
 
Figure 2: Schematic illustration of the genitourinary tract from the urine producing 
kidneys down to the urine storing bladder. Organs and their function are 
symbolised by equivalent mechanical components.[6] 
As Figure 2 shows, the “simplified” urinary tract (left side of the schematic 
illustration) consists of a funnel, which is comparable to the renal pelvis. The 
attached tube that represents the ureter is equipped with a peristaltic pump and 
valves. The peristaltic pump is a self-occluding pump and simulates the 
physiologic peristaltic effect of the natural ureter. Attached redundant and 
Background 
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unidirectional valves represent a closed tubular structure, which prevents a 
backflow of fluid. A reservoir is connected at the end of the system to store the 
urine. Under normal conditions, the urine storage capacity is in the range of 
350 ± 150 mL.[15] 
3.1.1 Anatomy and physiology of the ureters 
The ureters are bilateral tubes that connect the kidneys with the urinary bladder. 
Their length is in the range of 22 to 30 cm. Urine that is collected in the renal 
pelvis is transferred actively towards of the urinary tract.[13,14] The intravenous 
urogram in Figure 3 shows the abdominal region with bones and the urinary 
system that is made visible by means of a contrast agent.  
 
 
Figure 3: X-ray urography for the illustration of the urinary tract with the renal 
pelvis, ureter and urinary bladder.[16] 
It can be seen that the right kidney is compressed and shifted caudally. The upper 
kidney and adrenal gland are protected by ribs 11 and 12.[14] As depicted in Figure 
3, the renal pelvis is directed medially, so that pressures which are applied from 
the outer abdomen cannot lead to obstructions. This medial/parasagittal location in 
close proximity to large blood vessels shows the importance of these organs with 
respect to their function. Waste excretion is a vital necessity. A damage of this 
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system can lead to crucial consequences like the loss of a the kidney(s).[17] Thick 
muscles and bones shield this sensitive tubular structure. The pars abdominalis 
(cranial) is protected by the vertebral column and the musculus psoas, the pars 
pelvic (caudal) by the bony pelvic girdle.[13,14,18] The ureters are embedded in loose 
connective tissue, which makes them highly mobile. This mobility has to be 
ensured for the systematical transport of urine as well as for the protection against 
hyperextension. 
Figure 4 shows a cross-section of porcine ureter. The structure is comparable to a 
human ureter. 
 
 
Figure 4: Histological haematoxylin & eosin (HE) overview staining of a porcine 
ureteral cross-section. Starting at the top, Figure 4 shows (in counterclockwise 
direction) the lumen, the transitional urothelium, the underlying lamina propria, 
followed by longitudinally smooth muscles, the circularly smooth muscles and 
finally the serosa adventitia. Scale bar: 500 µm.[6] 
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The human ureter is about 1-10 mm thick.[19] As in Figure 4, five to seven 
physiological mucosal (transitional urothelium) wrinkles can be seen at the closed 
ureteral lumen; they are arranged longitudinally throughout the ureter. This shape 
can be observed under normal, relaxed conditions. The luminal surface is covered 
by a transitional epithelium, which consists of 4 to 6 cell layers.[13,18] The thickness 
of this layer is reduced during peristalsis due to expansion of the luminal cross-
section. Urothelial cells have an important protective function; they control immune 
responses, cell-cell signalling as well as the tissue permeability. Yet, the 
urothelium is one of the most impermeable tissues due to numerous tight junctions 
between the cells. This tight intercellular space allows to hold up strong 
concentration gradients between the urine and the plasma and to resist shifting pH 
values.[14,18,20–23] Urine osmolality varies over a broad range from 50 to 1200 
mosmole L-1. Fluid uptake, medications, renal performance, general health, blood 
pressure and osmolality as well as other factors influence the urine osmolality and 
volume.[14,19,24,25] In contrast to that, the physiological plasma osmolality range is 
290 ± 10 mosmole L-1.[13,26] The physiological pH value of urine varies between 4.5 
and 8, the average lies between 5.5 and 6.5.[14,19] Friedlander et al. (2014) found 
out that increasing age leads to a pH shift towards acidic values.[27] 
An elastic lamina (lamina propria) lies beneath the transitional urothelium. This 
lamina contains elastic proteins that ensure the distension of the luminal cross-
section while a urine bolus passes the ureter.[13,14,19] 
The lamina propria is covered by the tunica muscularis, which is necessary for the 
peristaltic effect that forwards the urine into the direction of the vesica urinaria 
(urinary bladder). The tunica muscularis can be divided into two smooth muscle 
layers: an inner (stratum longitudinale) and an outer circular layer (stratum 
circulare).[13,14,18] Additionally, the last third of the proximal ureter is equipped with 
a longitudinally arranged smooth layer on the outer surface.[18,19] 
An adventitia, made up of loose connective tissue, integrates the ureters into the 
surrounding tissue, ensures the blood supply and provides the elastic 
support.[13,14,19] 
The peristaltic effect of the ureter is required for an active transport of urine from 
the kidney towards the most caudal part of the system described, the urinary 
bladder. This is due to the fact that the force of gravity alone is not sufficient for 
draining. The resulting contraction of the smooth muscle is similar to the 
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contraction that is found in all other tubular hollow organs like the oesophagus, 
bowel, fallopian tube and many more. A schematic illustration in Figure 5 depicts 
the epithelium with its smooth muscle layers arranged longitudinally and circularly. 
The highlighted regions are contracting one after another to forward the urine. 
 
 
Figure 5: Schematic illustration of the peristaltic forwarding of a urine bolus 
induced by a contraction of the longitudinal smooth muscle layer, followed by a 
contraction of the circularly arranged smooth muscle layer.[6] 
Peristaltic forwarding of a droplet starts with the opening of the luminal cross-
section. This opening is a consequence of contracting longitudinally directed 
smooth muscle cells (SMC). Subsequently, the circular SMCs contract, preventing 
a reflux of urine, and press the urine bolus towards the urinary bladder. As a result 
of mechanical stress on the SMCs, the same procedure repeat itself. 
The contraction waves are assumed to start in the calix renalis region, in the deep 
renal pelvis.[28–30] The stimulus is transmitted myogenically in the smooth muscle 
cell membranes.[28,31] The contraction frequencies vary depending on the location 
in the urinary tract. Table 1 gives an overview about the sites and related 
frequencies. 
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Table 1: Contraction frequencies decrease with the distance to the renal pelvis.[28] 
Location Frequency [Hz] 
Calix renalis 0.190 
Pelvis renalis 0.150 
Pyleureteral junction 0.133 
Ureter 0.067 
 
Under normal conditions, there is a laminar flow of urine inside the ureterand the 
urine bolus passes the ureter together with the contraction stimulus in the 
transmission phase. In the relaxed phase, the ureter is occluded to prevent a 
reflux of urine towards the kidneys.[31,32] At a certain, critical frequency and flow 
rate, the urine nevertheless begins to flow back.[32] 
Table 2 shows the pressures inside the upper urinary tract and the urinary bladder. 
It can be seen that Shafik et al. (1998)[33] measured different pressures at different 
positions in the urinary system. The pressures range from 3 to 33 cm H2O and is 
highest in the ureters during peristalsis.[33] 
 
Table 2: Pressures in the upper urinary tract and the urinary bladder.[33] 
  Pressure [Pa] 
Mean Range 
Renal pelvis 450 ± 140 300-700 
Ureteropelvic junction 1460 ± 380 1100-1800 
(Ureter-) Basal 460 ± 110 300-600 
(Ureter-) During peristalsis 2660 ± 630 1800-3200 
Ureterovesical junction 1060 ± 1240 900-1400 
Bladder 510 ± 150 300-700 
Background 
 16 
3.1.2 Ureteral injuries 
The ureter is protected from other abdominal tissues, so that there is just a 
relatively small amount of ureteric injuries (1-2.5%) compared to all urogenital 
trauma.[34] 
Figure 6 shows a classification of ureteric injuries by cause, location and 
classification of the American Association for Surgery of Trauma (AAST). 
 
 
Figure 6: Classification of ureteric injuries according to their cause, location and 
AAST grading.[6] 
Traumas can be assigned to primary (direct) or iatrogenic (caused by medical 
interventions) injuries. Direct injuries include accidents, gunshots, malformations 
or diseases that affect the ureters. Iatrogenic injuries often occur during medical 
interventions like ureteroscopic, gynaecological, colorectal and vascular medical 
procedures.[35–37] 
A summary of two American studies about primary injuries inflicted by gunshots, 
stab wounds and blunt trauma included 761 cases. This summary shows that the 
upper ureter is affected more often (38.9%) than the mid (31.9%) and lower ureter 
(29.2%).[35,38] 
Taking a look at the causes of ureteral trauma, a European study revealed that as 
many as 75% of all cases of ureteric traumas are related to iatrogenic injuries. 
Furthermore, this retrospective study with 450 patients revealed that 74% of the 
ureteric trauma were located in the lower, 13% in the middle and 13% in the upper 
ureter.[39] 
Ureteric Injuries 
Cause 
Primary Iatrogenic 
Location 
Upper 
ureter 
Middle 
ureter 
Lower 
ureter 
AAST-
Classification 
Grade 
1-5 
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The same trend for primary and iatrogenic injuries was observed by 
D.J. Summerton et al.[34] From these studies it can be concluded that primary 
injuries are mainly related to traumas at the upper ureter and iatrogenic injuries to 
traumas at the lower ureter. 
It can be stated, however, that reliable data on iatrogenic injuries are difficult to 
obtain due to restrained or moderate publication of these incidents. The 
occurrences of iatrogenic injuries vary from 0.5 to 30%, but it may be assumed 
that this value is even higher.[40] 
In 1992, Moore et al. developed a classification to categorize the severity of 
ureteral injuries.[41] This 22-year-old classification is still used by the AAST and 
European Association of Urology (EAU) and provides the basis for the related 
groups of illnesses in the International Statistical Classification of Diseases and 
Related Health Problems (ICD). Table 3 shows the correlations between the AAST 
grading system, the ICD classifications of 1976 (ICD-9) and the recent 2014 
classification (ICD-10-CM).  
 
Table 3: Modified AAST grade of ureteral injuries according to EAU guidelines 
based on Moore et al. and the corresponding ICD codes.[34,41] 
AAST 
grade 
Type of 
injury 
Ureteral injury ICD-9 
(1976)  
ICD-10-CM (2014) 
I Hematoma Contusion or hematoma 
without devascularisation 
867.2/ 
867.3 
S37.10XAS31.001A 
II Laceration <50% transection 867.2/ 
867.3 
S37.10XAS31.001A 
III Laceration >50% transection 867.2/ 
867.3 
S37.10XAS31.001A 
IV Laceration Complete transection with >2 
cm devascularisation 
867.2/ 
867.3 
S37.10XAS31.001A 
V Laceration Avulsion with >2 cm 
devascularisation 
867.2/ 
867.3 
S37.10XAS31.001A 
 
Treatment planning for ureteral trauma is based on the cause, severity and 
location of the injury. There are at least 300 different surgical procedures 
available.[42] Basically, ureteral injuries from grades I to II (III) are supposed to be 
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drained by stenting, which may also prevent a collapse or a stricture, or with a 
nephrostomy tube.[34,35,41,43,44]  
3.1.3 Aetiology and pathogenesis of ureteric injuries 
Iatrogenic injuries often involve with symptoms like flank pain, incontinence, 
haematuria, fever, uraemia, hydronephrosis, fistula formation, urinoma, etc. 
Missing medical treatments may lead to further and more serious complications 
like infections, inflammation, fibrotic reactions and a total renal 
dysfunction.[17,34,38,45–47] Besides that, the replacement of ureters and the healing 
process become particularly complicated if the patient suffers from diseases like 
calculous disease, tuberculosis, endometriosis, diabetes, maldevelopment, 
bilharzial stricture and similar conditions.[17,34,48,49] In these cases, subsequent 
strictures may occur, which result in a dam of urine and the complications already 
mentioned.  
Occurrence of iatrogenic injuries can be reduced by using correct and state-of-the-
art instrumentation[50–52] as well as anatomical and surgical experience.[34,40,53] 
 
3.2 Tissue engineering in urology 
Tissue engineering in urology covers a wide range of biological tissue and organ 
substitutes from tissue-engineered bladders to urethras and ureters. 
Nevertheless, there is just one company, UroTiss GmbH Germany, which has an 
approved and licensed tissue-engineered product on the market. The MukoCell 
compound is a complete autologous tissue equivalent which is used for urethral 
reconstructions.[54,55] 
Reconstruction of ureters and urinary bladders are still being investigated and 
subject of clinical trials. Even though there are some promising results for the 
replacement of whole bladders, it is not yet a routine clinical application.[56,57] 
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3.2.1 Tissue engineering principles 
Growing functional organs for transplantation is not yet trivial. Figure 7 shows 
many different factors belonging to at least one of three different categories has an 
important influence on a tissue engineering project. For the sake of clarity, these 
are reduced to three major factors for each category. 
 
 
Figure 7: Functionalisation of a tissue requires three technologies that are 
dependent on each other.[6] 
In Figure 7, all demands on a bioreactor system for growing functional tissues are 
reduced to the co-cultivation of cells, mechanotransduction and the need for 
reliable hard and software. Mechanical stimulation of the biohybrids used, is 
essential to the intended functionalization. Cell culture technologies include 
co-cultivation, primary cell culture and cell seeding mechanisms. In this context, 
the isolation of primary cells from the patient’s tissue plays an important role for 
the personalised medical treatment with the generation of autologous tissues. 
Different seeding procedures need to be tested with the isolated cells in 
combination with the biomaterials to be used. Biomaterials are required to allow 
the co-cultivation of cells and they need to be biocompatible. At least tubular and 
planar material structures need to be available for initial in vitro tests. 
Functional Tissue Equivalent 
Bioreactor 
Technologies 
(Co)Cultivation 
of Cells 
Mechano-
transduction 
Reliable Soft- 
and Hardware 
Cell Culture 
Technologies 
(Co)Cultivation 
of Cells 
Primary Cell 
Culture 
Cell Seeding 
Mechanisms 
Biomaterial 
Technologies 
(Co)Cultivation 
of Cells 
Biocompati-
bility (in-
vitro/in-vivo) 
Planar/Tubular 
Format 
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All three technologies are dependent on each other. A lack in one component 
cannot be compensated by one of the others. 
3.2.2 Bioreactors 
Bioreactors can be defined as closed environmental vessels that provide a 
suitable culture environment to grow tissue. They enable highly precise control 
and measurement of parameters like pH, temperature, nutrient supply and waste 
removal, sterility and safety as well as pressure and gas supply. Continuous 
monitoring and sampling lead to high reproducibility, which is needed for 
biological, biochemical and chemical applications.[58–60] 
Individualised bioreactors are used for various tissue engineering purposes like 
generated bone and cartilage[61–64], skin[65], trachea[66], intestine[67], heart valves[68] 
and more. 
All these bioreactors serve the same purpose: they are used to generate three-
dimensional (3D) tissue equivalents by providing optimal supply of nutrients, gases 
and mechanical stress. They are the key features in modern tissue engineering, 
which needs to be biomimetic by copying a physiological environment.[12,69,70] 
Literature shows that mechanical conditioning with compression, elongation and 
pulsatile flow is important for growing tissue equivalents and their subsequent 
implantation. It enhances, cellular distribution, proliferation, differentiation and the 
mechanical properties of the tissue.[71–74] However, cellular effects like proliferation 
are cell-type specific and vary in depending on proliferative or contractile 
phenotypes.[61,73,75–77] 
Literature on cell culture technologies indicates that mechanical conditioning leads 
to an orientation of cells. This effect is regarded to be stress level and cell type 
dependent.[78]  
An overview of this literature with respect to applied stress magnitudes, 
frequencies and the consequences is given in Table 4. It can be observed that the 
obtained results are not consistent and difficult to compare, as not only the 
different cell types and passages used, but analytical and experimental setups 
(two or three-dimensional) as well. Nevertheless, it becomes clear that cells align 
themselves in the direction of low stress levels on two-dimensional substrates. 
This may be a reaction to reduce the applied stress.[78] 
Background 
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Table 4: Overview of literature dealing with cell culture technologies and mechanical stresses and the resulting orientation and 
proliferation of cells. NPS=not part of study, SIS=small intestine submucosa, BSM=bladder submucosa. 
Strain [%] Alignment in the 
direction of strain 
Frequency 
[Hz] 
2D/3D Proliferation Cell type/passage Source 
0 
2 
5 
0° 
90° 
90° 
0.0725 2D significantly reduced 
proliferation (beginning 
from 5%) 
porcine, oesophageal SMC; 
4-10th passage 
[78] 
10 ~70° 1 2D NPS human aortic vascular SMC; 
4-8th passage 
[79] 
0-6.7 random (0%) to 
parallel (6.7%) 
1 3D bulb NPS sheep aortic SMC; 
4-8th passage 
neonatal rat cardiomyocytes 
[80] 
0 
10 
random 
0° 
1 3D tube NPS aortic rat SMC; 5-8th passage [74] 
0-7 
7-24 
random 
90° 
1 2D significantly increased 
cell proliferation 
bovine aortic SMC; 
< 5th passages 
[81] 
0-20 NPS 0.000152 2D significantly reduced cell 
proliferation 
human bladder SMC;  
1-9th passage 
[82] 
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Strain [%] Alignment in the 
direction of strain 
Frequency 
[Hz] 
2D/3D Proliferation Cell type/passage Source 
0 
6 
20 
NPS 0.1 2D from 20% significantly 
increased proliferation 
human bladder SMC 2-5th 
passage 
[75] 
NPS NPS 0 
0.167 
0.667 
3D SIS significantly increased 
proliferation  
human, urine derived stem 
cells; subsequent 
differentiation to UC/SMC 
[83] 
NPS NPS 0 
0.167 
0.667 
3D BSM significantly increased 
proliferation 
human UC/SMC [84] 
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3.2.3 Cell culture technologies 
The term cell culture technology includes all methods used for the in vitro 
cultivation of cells. This includes gaining of cells as well as evaluating cellular 
effects and responses as a result of an experiment. The experiments are 
performed outside the body, i.e. in vitro or ex vivo. It is important to differentiate 
between extracted organs that are used ex vivo and tissues or cells that are 
cultured in vitro. In vitro conditions are generally different to the situation in vivo, 
although organ baths for pharmacological applications are seen as in vivo 
situation. Nevertheless, the whole body system with its signalling molecules like 
hormones or cytokines is missing in these experiments. Due to its complexity, the 
in vivo system cannot be reproduced under laboratory conditions. 
3.2.4 Biomaterials 
In addition to the bioreactor technologies, there are biomaterials that are important 
for successful tissue engineering (TE). Biomaterials serve as a 3D scaffold for the 
generation of tissue equivalents. Therefore, these materials need to be 
biocompatible in vitro and in vivo. It is essential to the success of a TE project that 
the mimicking of a natural matrix is as accurate and precise as possible to 
enhance tissue growth and regeneration, avoiding side effects like fibrosis, 
inflammation and others. Figure 8 shows that biomaterials are divided into 
naturally derived (decellularised) and synthetically manufactured materials. Both 
groups are characterised by specific advantages as to their biocompatibility, 
reproducibility and controllability of (mechanical) features.[73,85] 
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Figure 8: An assortment of biomaterials used in urological regenerative medicine 
according to [71,83,85–87]. The groups are divided into living autologous tissues (1), 
decellularised (2), natural biomaterials (3) synthetic and naturally derived 
biomaterials (4).[6] 
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At first sight, autologous tissues (Figure 8) seem to be the most suitable materials 
for the replacement of damaged organs. Nevertheless, there is still a high risk for 
negative implications. Bridging tissues for urological applications are often prone 
to necrosis, mucous production, inflammation and obstruction with frequent 
stricture formation and scarring at the sites of anastomosis.[88,89] 
Decellularised matrices are natural 3D scaffolds, obtained by lysing and washing 
out of cells. This group is favoured for its high biocompatibility that is enhanced by 
biomimetic factors that are able to promote the tissue formation after 
recellularisation.[85,90,91] Exactly these residual heterogenic factors, however can 
also lead to negative side effects like immunological reactions, fibrosis or 
calcification.[83,92] Generally, physiochemical and mechanical characteristics 
depend on numerous variables like the location of extraction, donor age, 
manufacturing and sterilisation procedures and more. Thus, batch-to-batch 
variations impair the reproducibility.[83,90] Even so, a recellularisation can be 
enhanced by means of mechanical stimulation.[84] 
Manufactured biomaterials are split up into synthetic and naturally derived 
biomaterials. Synthetic biomaterials are superior in their reproducibility ensuring a 
constant level of quality as well as their highly controllable characteristics like 
overall dimensions, pore sizes or degradation rates.[71] The application of pure 
synthetic materials like Vicryl® or Teflon® is often leads to mechanical failure or 
stone formation, abnormal fibroblast deposition and scarring.[86]  
As a conclusion, it can be said that best functioning mechanical and biological bio-
implants are still offered by combinations of synthetic and naturally derived 
biomaterials. This combination can increase mechanical and biological 
characteristics at the same time. The hollow structures in the body require the 
synthetic materials to keep their openings. Otherwise they will collapse. To 
increase the biocompatibility it is necessary to combine them with biological 
materials. These so called composites (temporarily) strengthen fragile and 
collapsible constructs with increased biocompatibility.[74,85–87] This method is 
biomimetic as it copies the basic structural setup of hollow organs. Different (bio-) 
mechanical properties are provided for tissue specific cell types.[85] 
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4 Materials and Methods 
In this study, tissue engineering principles were used to prove and enhance a new 
bioreactor system for growing functionalised tubular organ structures for 
application in the genitourinary tract. To achieve this, biomedical skills i.e. cell 
culture technologies, mechanical engineering and material sciences were used. 
The following chapter shows materials and chemicals as well as classical methods 
and protocols used in this study. 
4.1 Materials used in this study 
 
Description Company Modell/Order 
Code 
Parameter 
Air Pump Hagen Elite 800  
Applicator Medmix Systems 
AG 
Double-Cartridge 
Delivery System 
(S) 
Cartridge Volume 
16 mL 
Autoclave Systec 2540EL 121 °C, 20 min 
Battery APC Beck-UPS Pro 900  
Bottle Schott Duran 1112627 GLS 80, 500 mL 
Bottle Schott Duran 21801245 GL 45; 100 mL 
Cell Counter BioRad TC20™  
Cell Culture Flasks Nunc 156499 75 cm² 
Cell Culture Flasks Nunc 159910 175 cm² 
Cell Culture Flasks Nunc 132913 500 cm² 
Centrifuge Heraeus Biofuge 15R 290 g 
Centrifuge Tubes VWR 525-0156 50 mL 
Centrifuge Tubes VWR 525-0150 15 mL 
Clean Bench Heraeus Hera Safe  
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Description Company Modell/Order 
Code 
Parameter 
Counting Slides BioRad 145-0011  
Critical point dryer BAL-TEC/Leica 
Microsystems 
CPD030  
Cuvettes Hellma 115B-QS 200-2500 nm; 
400 µL 
Dialysis Membrane CarlRoth GmbH + 
Co. KG 
2711.1 Cut-Off 6000-
8000 MW 
Disposable Needle CarlRoth GmbH + 
Co. KG 
C630-1 0.8120 mm, 
21G4 ¾’’ 
Drape Sheet Lohmann & 
Rauscher 
33033 7590 cm 
Extension Pump 
head 
Watson-Marlow 314X; 
033.4431.000 
 
F-Fittings BESTA-Technik 
GmbH 
F-120 PEEK 
Gauze Swabs Fink & Walter 321063 1010 cm 
HPLC Starter Kit Jasco  Fittings PEEK, 
tubing PEEK 
di = 0.5 mm 
Incubator  HiTec Zang Ramos 37 °C; 5% CO2 
Incubator Heraeus Hera Cell 37 °C; 5% CO2 
Instruments tray 
with lid 
Bochem 8716 30020050 mm 
Kyphoplasty Balloon 
Catheter 
Allevo Joline S9401 Balloon Ø16 mm; 
Balloon length = 
10 mm 
LabBox®2 HiTec Zang LabBox®2 Serial: 020906599 
LabDos HiTec Zang Vario4 
P100 
V4.1.2 
V3.5.4 
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Description Company Modell/Order 
Code 
Parameter 
Light microscope Leica DM 6000B Digital camera: 
JVC KY-S75U  
Limit switch Cherry BB1C-A1LC 6 A, 250 V 
Locating Pins MISUMI SPSS-D3.0-L10.0 Stainless steel 
LUER to M6 Vieweg GmbH 990063-M6 Stainless steel 
Male LUER to 10-32 
Female 
BESTA-Technik 
GmbH 
P-656 PEEK 
Microcentrifuge 
Tubes 
Simport T330-7N 1.5 mL 
Microtome Blades FEATHER A35  
Mounting Stud BESTA-Technik 
GmbH 
P-645 PCTFE 
Multiwell Nunc 142475 24 wells 
Neubauer Counting 
Chamber 
Marienfeld Cat.No.0640010  
O-Ring Research Centre 
Jülich 
311.01.043 
311.01.011 
224 mm; 
1.58 mm 
Osmomat Gonotec 030  
Oven Heraeus T5060 125 °C 
Pasteur pipettes Hirschmann 
Laborgeräte GmbH  
9250101 7150 mm 
Petri Dish Nunc 172958 10020 mm 
pH - Electrode Schott Instruments SL 82-120 pHT  
pH - Meter Mettler Toledo Seven Multi  
Phase Contrast 
Microscope 
Zeiss Axiovert 25  
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Description Company Modell/Order 
Code 
Parameter 
Pipette Filler 
Hirschmann 
Laborgeräte 
Pipetus  
Pipette Tips Eppendorf 
0030000.870 
0030077.148 
0030000.919 
0030000.978 
0.5 µL – 10 µL 
10 µL – 100 µL 
100 µL – 1000 µL 
500 µL – 5000 µL 
Pipettes Eppendorf Research variable 
0.5 µL – 10 µL 
10 µL – 100 µL 
100 µL – 1000 µL 
500 µL – 5000 µL 
Precision Syringe 
Doser 
HiTec Zang SyrDos Resolution: 48.000 
steps 
Pressure Sensor Keyence AP-13S#120327 
AP-
V80WP#1145669 
1 MPa 
4-20 mA 
Scale Sartorius Extend ED 124S  
Screw Cap GLS 80 BOLA XF072-110622 3NTP ¼”,  
1PG 13.5,  
1M141.5 
Septum VWR 548-0480 12.9 mm GL14, 
silicone-PTFE 
Septum VWR 11020115 11 mm; PTFE-
silicone-PTFE 
Serological Pipettes CarlRoth GmbH + 
Co. KG 
N236.1 
N239.1 
N242.1 
N245.2 
2 mL 
5 mL 
10 mL 
25 mL 
Shut-Off Valve BESTA-Technik 
GmbH 
P-732 PEEK 
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Description Company Modell/Order 
Code 
Parameter 
Single-Hand Quick-
Connect 
neoLab Migge 
Laborbedarf - 
Vertriebs GmbH 
2-6306 
2-6308 
2-6315 
Stainless steel; M5 
Spectrophotometer Jasco V-550  
Sterile Gloves Sempermed 
Supreme 
822751721  
Sterile Syringe Filter VWR 514-0073 PES, 0.2 µm 
Suction Pump IBS Integra 
Bioscience 
Vacusafe comfort  
Syringe CarlRoth GmbH + 
Co. KG 
T549.1 
0058.1 
0057.1 
50 mL 
10 mL 
5 mL 
Tube BOLA S1810-38 di = 4 mm, 
da = 5 mm 
PTFE 
Tube Marprene 902.0032.016 di = 3.2 mm, 
da = 6.4 mm 
Marprene 
Tube VWR 228-1082 di = 3.2 mm, 
da = 6.4 mm 
Silicone 
Ussing Chamber Dipl.-Ing. 
K.Mussler 
  
Water bath Huber CC2 37 °C 
Water bath PolyScience 20-LM 37 °C 
Wing Bolt MISUMI CHBS4-20 M420 mm, 
stainless steel 
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4.2 Chemicals used in this study 
Description Company Order Number Trading Unit 
Acetic Acid 
CarlRoth 
GmbH + Co. 
KG 
733.2 2.5 L 
Acetone 
CarlRoth 
GmbH + Co. 
KG 
9372.1 1 L 
Acheson Silver Dag 1415 Plano GmbH G3692 25 g 
Ammonium chloride Sigma A4514 500 g 
Amphotericin PAA P11-001 100 mL 
Calcium chloride Merck 208290.1000 1 kg 
Chloroform 
CarlRoth 
GmbH + Co. 
KG 
3313.1 1 L 
Creatinine Sigma C4255 100 g 
Cyklokarpron®/Tranexamic 
acid 
Pfizer 6376165.00.00 1000 mg 10 mL-1 
Disodium hydrogen 
phosphate 
Merck 6579.1000 1 kg 
DMEM – with GlutaMAX™ Invitrogen 61965-026 500 mL 
Ethanol 70% 
CarlRoth 
GmbH + Co. 
KG 
T868.1 1 L 
Description Company Modell/Order 
Code 
Parameter 
Wing Nut MISUMI CHNS4 M4, stainless steel 
Y-Connector BESTA-Technik 
GmbH 
P-512 PEEK 
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Description Company Order Number Trading Unit 
Ethanol 99.8% 
CarlRoth 
GmbH + Co. 
KG 
9065.3 1 L 
Fetal bovine serum Gibco 25300-062 500 mL 
Fibrinogen, human plasma 
Calbiochem/ 
Merck 
Millipore 
341576-1GM  1 g 
Gentamicin Sigma G1272 100 mL 
Glucose Merck 8337.1030 1 kg 
L-Ascorbic acid 2-phosphate 
sesquimagnesium salt 
hydrate 
Sigma A8960 5 g 
Magnesium chloride Sigma M8266 100 g 
Microscope BioZero BZ 8100E  
Penicillin/Streptomycin Sigma P4333 100 mL 
Phosphate buffered saline Invitrogen 14190-094 500 mL 
Poly-Alcohol Antiseptica 
 
PZN 05905148  
 
200 mL 
Potassium chloride Merck 4936.1000 1 kg 
Potassium dihydrogen 
phosphate 
CarlRoth 
GmbH + Co. 
KG 
P018.1 500 g 
Sodium bicarbonate Sigma 56297 250 g 
Sodium chloride 
CarlRoth 
GmbH + Co. 
KG 
3957.1 1 kg 
Sodium citrate dihydrate Merck 1.1200500.1000 1 kg 
Sodium dihydrogen 
phosphate 
Merk 6346.1000 1 kg 
Sodium hydroxide Roth 9356.1 1 kg 
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Description Company Order Number Trading Unit 
Sodium sulphate 
CarlRoth 
GmbH + Co. 
KG 
P032.1 500 g 
Storage solution for pH 
electrodes 
CarlRoth 
GmbH + Co. 
KG 
9608.1 500 mL 
Talcum powder Drugstore   
Tris base Sigma 252859 500 g 
Tris HCl 
CarlRoth 
GmbH + Co. 
KG 
9090.2 500 g 
Trypan blue Sigma T8154 100 mL 
Trypsin/EDTA Gibco 25300-054 100 mL 
Uera 
CarlRoth 
GmbH + Co. 
KG 
7638.20 5 kg 
Optimaix 3D Sponge1 
Matricel 
GmbH 
 
di = 6 mm; 
da = 14 mm 
Polyvinylidenfluorid ITA Aachen 
Trickot E30 
EAC 10 
 
 
 
4.3 Buffers and cell culture media used in this study 
Buffers are also called balanced salt solutions (BSS). Different BSS were applied 
to cells to provide constant pH values as well as an isosmotic surrounding. For the 
preservation of the structural and functional integrity of proteins, the pH value is an 
important parameter.[93] Besides that, applying physiological salts with 
physiological concentrations ensures the control of the cells’ water household.[94] 
Generally, a physiological plasma osmolality of 290 ± 10 mosmole kg-1 and a pH of 
7.4 was desired and adjusted for the utilised buffers.[94,95] The only exception was 
synthetic urine, which had an higher osmolality (760 mosmole kg-1) that was in the 
range of physiological urine as well as a lover pH value (5.6–5.8). 
All components were weighed with an analytical scale (Sartorius) and were 
subsequently dissolved in distilled water. 
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4.3.1 Tris-buffered-saline (TBS) 
Tris-buffered saline was used in this study for dialysing dissolved fibrinogen as 
well as for the fibrin preparation. The composition used is listed in Table 5.  
 
Table 5: Composition of Tris-Buffered-Saline. 
Tris-Buffered-Saline 
Substance Concentration [mmol L-1] 
Potassium chloride 2.68 
Sodium chloride 0,14 
Tris Base 5.28 
Tris HCl 27.66 
 
4.3.2 Phosphate-buffered-saline (PBS) 
The composition of phosphate-buffered-saline (PBS) can be traced back to 1954 
and the scientists R. Dulbecco and M. Vogt. They developed the basic formulation 
of PBS, which is the most common balanced salt solution for general cell culture 
applications.[96] However, in this study calcium and magnesium free PBS was used 
with the following ingredients: 
 
Table 6: Composition of Phosphate-Buffered-Saline. 
Phosphate-Buffered-Saline 
Substance Concentration [mmol L-1] 
Disodium hydrogen 
phosphate 
8.06 
Potassium chloride 2.67 
Potassium dihydrogen 
phosphate 
1.47 
Sodium chloride 137.93 
4.3.3 Artificial urine 
Artificial urine was used for passive diffusion experiments in combination with an 
Ussing chamber to characterise the performance of the engineered prosthesis in 
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comparison to the natural material.[97] As mentioned in Chapter 3.1.1 the 
physiological urine osmolality can vary between 50 and 1200 mosmole L-1. The 
applied buffer had an osmolality of 760 mosmole L-1 and a pH value of 5.8. The 
basic formulation can be traced back to Griffith et al. 1976[98]. In this study, the 
applied composition was adapted from Montzka et al. (2010)[97] and did not contain 
sodium oxalate. 
 
Table 7: Composition of synthetic urine with its components and concentrations 
according to [98] and modification after [97]. 
Artificial Urine 
Substance Concentration [mmol L-1] 
Ammonium chloride 18.69 
Calcium chloride 5.86 
Creatinine 9.72 
Magnesium chloride 6.84 
Potassium chloride 21.46 
Potassium dihydrogen phosphate 20.57 
Sodium chloride 78.7 
Sodium sulphate 16.19 
Tri-sodium citrate dihydrate 2.2 
Urea 416.25 
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4.3.4 Krebs buffer 
Krebs buffer was used for diffusion experiments in an Ussing chamber (see 
Chapter 4.4.1.4), too.[97] This buffer was adjusted to pH 7.4 and an osmolality of 
290 ± 10 mosmole L-1. 
 
Table 8: Composition of the applied Krebs buffer solution. 
Krebs buffer 
Substance Concentration [mmol L-1] 
Calcium chloride 2.5 
Glucose 11.5 
Magnesium chloride 1.2 
Potassium chloride 4.7 
Sodium bicarbonate 25.0 
Sodium chloride 117.0 
Sodium dihydrogen 
phosphate 
1.2 
 
4.4 Cell culture technology 
Cell culture technologies include all methods, principles and tools that are applied 
on tissues or cells under artificial environmental conditions (see Chapter 3.2.3). In 
the following chapter, the most important and used methods and protocols are 
presented. 
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4.4.1 Measurement of biochemical parameters 
4.4.1.1 pH value 
The pH value can be measured in various ways. Basically, there are two different 
methods: non-electrochemical and electrochemical.[99] Non-electrochemical 
methods, e.g. colorimetric methods, show great disadvantages, because of the 
subjective evaluation. For that reason, electrochemical methods and especially the 
use of pH glass electrodes are most common in scientific laboratories. Standard 
glass electrodes show the following setup within a measurement chain: 
 
 
Figure 9: Schematic illustration of a measurement chain to evaluate the pH value 
in a liquid analyte. The chain consists of a measurement electrode that is 
equipped with a thin glass membrane and a temperature sensor. Like the 
measurement electrode, a reference electrode with its diaphragm is connected to 
a voltmeter or pH-meter, too.[6] 
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(1) 
The objective is to measure a potential drop at the glass membrane of the 
measurement electrode to determine the pH value in the analyte. This potential 
can be read out with a voltmeter or pH meter. A pH meter is able to convert the 
potential into a pH value. The analyte’s temperature needs to be followed because 
it influences the measurement. Reference electrodes have a constant potential 
and close the electrical circuit. Typically, this measurement chain is realised in a 
single-rod measuring cell. 
Basically, potential drops and measured voltages correlate to a specific pH value 
and is described for optimal glass electrodes by the Nernst equation[99,100]: 
 
𝑈 = 𝑈0 −
𝑅 ∙ 𝑇
𝐹
∙ log⁡[𝐻3𝑂
+] 
 
U = measured potential 
Uo = standard electrode potential 
R = gas constant 
T = absolute temperature 
F = Faraday constant 
4.4.1.2 Temperature 
Temperature measurements are important for in vitro cultivation processes 
because cell metabolism has a temperature optimum. For this study, a 
physiological temperature of 37 °C was kept constant during incubation processes. 
Measurements inside the bioreactor system were performed with Pt100 thermal 
sensors that had a typical electrical resistance of 100 Ω at 0 °C. Increasing 
temperatures lead to increasing resistances and were read out with a LabBox®2. 
The slope of this increase is described by temperature coefficients in specific 
temperature ranges. Coefficients are given from 3.8610-3 K-1 to 3.8910-3 K-1 at 
20 °C and 40 °C or 3.8510-3 K-1 for the whole range.[99,101] 
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4.4.1.3 Osmolality 
The two terms osmolality and osmolarity are related to each other by their basic 
definition, but differ with respect to the solvent. Both describe the osmotic pressure 
of a solution. They are defined as concentrations of molecules that contribute to 
the osmotic pressure.[102] Basically, there is just very little difference between 
osmolarity and osmolality when water is the solvent.[95,103] Osmolality refers to 
osmole kg-1 and osmolarity to osmole L-1 of the applied volume. 
Generally, measurements are performed with an osmometer. The freezing point of 
the solution refers to pure water. One osmole kg-1 leads to a decrease of the 
freezing point by 1.85 °C.[104] 
In this study, evaluations of the osmolality were performed with an Osmomat 030. 
Normally, buffer solutions were adjusted to 290 ± 10 mosmole kg-1. Adding of 
distilled water reduced the osmotic pressure of prepared solutions, whereas 
physiological salts (i.e. sodium chloride) increased the osmotic pressure. There 
was just one exception with the synthetic urine, where the osmolality was in the 
range of 760 mosmole kg-1. 
4.4.1.4 Diffusion of molecules in an Ussing chamber 
Tissue-engineered, fibrin-based prosthesis were characterised with respect to their 
tightness against urea and creatinine. Two Ussing chambers can be seen in 
Figure 10. An Ussing chamber consisted of two half shells. 
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Figure 10: Scheme of an “Ussing” chamber used for passive diffusion 
experiments. For this study, the chamber consists of two half shells, where the 
tissue is clamped in between.[6] 
The specimen to be characterised was put in between the two half shells, so that 
the tissue separated the two media reservoirs from each other. A specimen mount 
avoids a slipping of the tissue. Shaft locking clips on the two long sides of the 
chamber held both half shells together. The presented and applied model had a 
tissue-cross-section of 67.1 mm2 (14.55 mm2) and reservoirs contained 5 mL 
buffer solution. The gas lift for a homogenous mixture was operated with an 
aquarium pump. Valves located between the pump and the Ussing chamber were 
adjusted so as to insure an inflow of 5-10 bubbles per minute. Temperature was 
kept constant at 37 °C by placing the Ussing chamber into a water bath. 
Figure 11 indicates the starting conditions that were used in this study. The Ussing 
chamber on the left contained 5 mL artificial urine (see Chapter 4.3.3) and 5 mL 
Krebs buffer (see Chapter 4.3.4). Specimens were placed in between the two 
chambers. In all cases, the luminal surface of the prostheses was arranged 
towards the synthetic urine. Regular sampling of 1 mL was performed after 0.5, 1, 
1.5, 2, 3, 4, 5, 6, 7 and 8 hours to investigate the passive diffusion of urea and 
creatinine. Samples were taken from the Krebs buffer side. Sampling volumes 
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were replaced by fresh, preheated (37 °C) Krebs buffer solution. All samples were 
analysed in the veterinary laboratory of the RWTH Aachen University Hospital, 
Aachen. 
 
 
Figure 11: Starting conditions A) in the Ussing chamber with synthetic urine 
(yellow, left reservoir) and Krebs buffer (blue, right reservoir). Theoretical 
equilibrium B) conditions in the Ussing chamber, where both reservoirs (green) 
contain the same amounts of urea and creatinine.[6] 
4.4.2 Cell culture medium preparation 
In this study, three different cell culture media were applied for the following 
processes: 
Medium I:  Preparation of primary cell cultures 
Medium II:  Proliferation of primary cell cultures  
Medium III:  Application in the bioreactor system 
Cell culture medium I consisted of Dulbecco's modified eagle's medium (DMEM) 
supplemented with 10% (V/V) fetal bovine serum (FBS), 1% (V/V) gentamicin and 
1% (V/V) amphotericin. 
Standard cell culture medium II was made up of DMEM supplemented with 10% 
(V/V) FBS. This medium did not contain any antibiotics and was applied during the 
cultivations and proliferations of isolated porcine smooth muscle cells (SMC). 
A) B) 
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Cell culture medium III was applied for the fibrin-based prosthesis, based on the 
formulation by [105,106] and contained DMEM, 1% (V/V) penicillin/streptomycin, 1 
mM L-ascorbic acid-2-phosphate and 0.5 mg mL-1 Cyklokarpron®. L-ascorbic acid-
2-phosphate was added to improve tissue generation.[107,108] The originally applied 
aprotinin was replaced by Cyklokarpron® to stabilise tissue constructs and regulate 
fibrin degradation.[109,110] 
4.4.3 Passaging of cells 
Splitting of cells followed standard cell culture technology protocols as described 
by[111,112]. Cells were washed twice with preheated (37 °C) PBS to remove 
disturbing ions that inhibit the Trypsin/EDTA solution. Trypsin/EDTA contained the 
serine protease trypsin and the ion chelator ethylenediaminetetraacetic acid to 
detach adhering cells. Cell culture flasks containing the cells and an appropriate 
amount of Trypsin/EDTA (see Table 9) were put into the incubator. The 
detachment process was monitored regularly using an inverted light microscope. 
When cells had detached, adding of preheated (37 °C) standard cell culture 
medium II, inhibited the digesting enzyme trypsin. Suspensions were pipetted into 
50 mL centrifuge tubes and were centrifuged for 5 minutes at 280 g. A vacuum 
pump was used to remove supernatants before cell pellets were resuspended 
carefully with 1 mL cell culture medium II. 
 
Table 9: Volumes of PBS, Trypsin/EDTA and cell culture medium that were added 
to cell culture flasks in accordance with [105]. 
Cell culture 
Flask 
PBS [mL] Trypsin/EDTA 
0.05% [mL] 
Cell culture 
medium [mL] 
T75 5 3 10 
T175 12 7 25 
T500 30 15 60 
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This procedure is followed by the counting of the cells for a subsequent seeding 
them with a defined cell density. For primary porcine smooth muscle cells it could 
be observed that a seeding density of >2000 cells cm-2 was advisable to 
accelerate cellular proliferation. 
4.4.4 Cell counting 
All cells in this study were counted with the BioRad TC20™ cell counter. This 
automated device can be used to count cells and determine their viability by 
means of Trypan Blue staining. Cell counting was performed according to the 
manufacturer’s instructions.[113] To this end, a 1:1 dilution was prepared and 10 µL 
of a cell suspension were mixed with 10 µL Trypan Blue in a micro centrifuge tube. 
Ten µL of this suspension were put into disposable counting slides (BioRad). The 
counting slides were inserted into the TC20™ device and results were read out. 
Cellular concentrations of 5104-107 were not exceeded to obtain reliable 
measurements.[113] Results were checked again through evaluation of the particle 
sizes. Cell clots were made visible as big particles in the histogram and indicated 
on the front panel of the TC20™. A gating process allowed to exclude oversized 
particles from the evaluation process. The gates were set to 12-19 µm. 
4.4.5 Isolation of primary cells 
Isolation of primary cells was performed from porcine urinary bladders that were 
obtained from a local slaughterhouse. The bladders were transported in sterile 
glass containers with preheated (37 °C) cell culture medium, 1% (V/V) gentamicin 
and 1% (V/V) amphotericin.[97] 
Urinary bladders were placed inside the laminar flow hood on a sterile drape 
sheet. Excessive tissue was removed with a set of scissors, tweezers and clamps. 
After cutting the urethra, the bladders were opened with another sterile scissor. Y-
shaped incisions were performed medially to place bladders flat on the surgical 
drape. The luminal surfaces were directed to the topside. 
For following steps, a new set of sterile scissors was used. The mucosal layer was 
removed completely by means of scissors and tweezers. Fine tweezers were used 
to lift the elastic mucosal layer (urothelium), which was then cut. Subsequently, it 
was possible to dissect the exposed smooth muscle cell layer. 
Cutted smooth muscle tissue was collected in a petri dish, before it was minced 
into fragments of approximately 1 mm3. About 20-25 fragments were placed in 
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close proximity in T75 cell culture flasks. A sterile 5 mL serological pipette was 
used to distribute the tissue inside the cell culture flask. Fragments were allowed 
to dry inside the flasks for 20 minutes before 15 mL cell culture medium I (see 
Chapter 4.4.2) were added at the side of the flasks. Care handling ensured the 
adhesion of the tissue fragments. Flasks were put into the cell culture incubator at 
37 °C, 5% CO2 and 100% humidity. Cell culture media was replaced by preheated 
(37 °C) standard medium II (see Chapter 4.4.2) after 1 week. Detached tissue 
fragments were removed by pipetting. Cells were allowed to grow for about 2-3 
weeks before closely spaced cell population inside the flasks made passaging 
necessary. The passaging process was performed according to the description 
given in Chapter 4.4.3. For fibrin-based experiments cells were transferred into 
T175 flasks in passage 1 and in T500 flasks in passage 2. 
 
4.5 Histology 
4.5.1 Fixation and dehydration of tissues 
For further evaluation, samples needed to be stabilised in a fixative. In this study, 
Carnoy’s fluid was used to stop cellular activity and to fix cells. Carnoy’s fixative 
consisted of 60 mL ethanol 99.9%, 30 mL chloroform and 10 mL acetic acid.[114,115] 
This fixative was used because of its advantages with respect to 
immunohistochemistry of tissue-engineered constructs. An application of Carnoy’s 
fluid does not requires excessive antigen retrieval, which may impair the staining 
or visualisation of the samples.[115] Fibrin prostheses’ samples were incubated for 
4 hours, collagen based constructs for up to 8 hours. 
To enable further classical staining methods and scanning electron microscopy, 
the fixative needs to be replaced by ethanol 99.9% or acetone 99.9%.[114] 
Tissue-engineered samples were dipped in ethanol solution of different 
concentrations (70%, 80%, 90% and twice in 99.9%) for at least 20 minutes per 
solution. For classical histology, samples were stored in 99.9% ethanol. All other 
samples were dipped gradually into acetone (acetone/ethanol (v/v): 20/80; 40/60; 
60/40; 80/20; 90/10; 100/0; 100/0). 
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4.5.2 Classical staining and light microscopy 
Classical staining was carried out by the Aachen Interdisciplinary Centre for 
Clinical Research (IZKF). The samples were embedded in paraffin, cut into 5 µm 
slices and stained with Haematoxylin & Eosin (HE). HE is the most common 
staining and provides an overview of the sample after a very short period of time. It 
gives the opportunity to evaluate the structural setup of tissues with their cellular 
distribution. The typical dark blue/purple coloration results from the haematoxylin, 
whereas strong reddish/pink coloration is caused by the eosin. Generally, 
connective tissue and cytoplasm are stained by the eosin, while the haematoxylin 
stains the nucleus of cells.[114,116] 
Classical light microscopy is limited to the visible light spectrum that needs to pass 
the analysed sample. The resolution of a light microscope is strongly related to the 
wavelength of the applied light and the numerical aperture of the optical system. 
Under normal conditions, the limit value for lateral resolution of a light microscope 
is approximately 0.2 µm.[114,117] This value expresses the distance between two 
objects that is necessary to identify them as two separate objects.  
As this type of microscopy is not suitable for thick, lightproof tissues and for the 
evaluation of their outer surface, the scanning electron microscopy was used for 
this purpose. 
4.5.3 Critical point drying (CPD) and scanning electron microscopy 
Critical point drying (CPD) is a method to dry biological samples to prepare them 
for scanning electron microscopy. Other possibilities are drying them in 
environmental air or freeze-drying. However, CPD has the advantage that the risk 
of collapsing samples or damage due to ice crystal formation is reduced.[114,118] 
First the samples were set into the CPD-device. The pressure chamber was 
closed tightly and the sample was cooled to 8 °C. Liquid carbon dioxide (CO2) 
gradually replaced the acetone inside the chamber. The CO2 and the sample were 
heated up to 40 °C, which resulted in an increasing pressure. Consequently, the 
critical point of CO2 (74 bars, 31 °C) was exceeded.
[114,118] This enables a 
borderless phase transition from liquid to a gaseous. The gas was vented and the 
samples were taken out of the pressure chamber. 
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Figure 12: Phase diagram for CO2, according to 
[119]. The critical point for CPD 
can be exceeded at pressures >73.8 bars and temperatures >31 °C. Both 
conditions need to be fulfilled at the same time for a prompt phase transition.[6] 
After that, the samples were set onto holders for inserting them into the scanning 
electron microscope (SEM). The electrical connection between the holders and the 
samples were improved by applying Silver Dag 1415. Then, a gold-palladium 
(AuPd (80:20)) layer was added by sputtering. Collagen based scaffolds were 
sputtered for 1 minute, while fibrin-based prostheses were sputtered for 2 minutes. 
Subsequently, the samples were analysed with an ESEM Quanta 400 FEG. 
Scanning electron microscopy is used to analyse the outer surface of objects. 
Additionally, modern SEMs are able to analyse the material composition of the 
surface. Both are dependent on electrons that are ejected from a glow filament. 
This filament forms a cathode and released electrons are accelerated through a 
circular anode. Magnetic fields guide and focus these electrons onto the 
specimen. A vacuum inside the microscope avoids interaction of the accelerated 
electrons with the ambient air. The electrons interact with the sample’s surface, so 
that secondary and backscattered electrons can be used for imaging the sample’s 
topography and for the image contrast. Secondary effects like characteristic x-rays 
give information about the composition of the specimen’s upper layer.[120] 
In such cases, the typical resolution is in the range of 2 nm.[118] 
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4.6 Application of scaffold materials 
4.6.1 Optimaix 3D Sponge1 
With a relative amount of 25%, collagen is the most abundant protein in the human 
body, and it appears in at least 27 different forms. This protein mostly consists of 
glycine, proline and hydroxyproline.[13] 
Due to the high amount of collagen in the body and its availability there is the idea 
to use this extracellular matrix protein for tissue engineering purposes. Collagen 
type I is one of the most common extracellular matrix (ECM) proteins and its fibril 
structure is illustrated in Figure 13. 
 
 
Figure 13: Structural setup of a fibril collagen according to [121].[6] 
Figure 13 shows that collagen type I forms a super helical structure out of three 
polypeptide chains with a length of about 300 nm and a diameter of 1.5 nm. A 
single loop of the super helix has a length of 10.4 nm.[121,122] 
Optimaix is a patented scaffold material based on type I collagen and low amounts 
of elastin. A specific freeze-drying manufacturing process results in its 
characteristic structure. Interconnected pores are parallel oriented with a width of 
20-50 µm.[123] Thus, the cross-sectional area equals 1250-7850 µm2, assuming 
circular pores. 
The Optimaix 3D was tested by Montzka et al. (2010) with respect to its suitability 
for urological applications and showed useful results with respect to cellular 
proliferation and biocompatibility.[97] Based on these findings, a tubular matrix was 
developed with radially oriented pores. This new Optimaix 3D Sponge1 was used 
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in this study for the bioreactor system. Moreover, an in-vivo study (UroRepair) with 
this material in Göttinger Minipigs revealed an excellent performance in the urinary 
bladder. In this study, unseeded, with urothelial cells or smooth muscle cells 
seeded, and co-cultivated Optimaix 3D matrices with a size of up to 12 cm2 were 
applied. Autologous, primary smooth muscle and urothelial cells were used to 
generate tissue for the replacement of injured bladders. No effects like stone 
formation, inflammation reaction or rejection were observable after about 6, 12, 18 
and 26 weeks of implantation.[124–126] 
4.6.1.1 Seeding procedures 
The seeding procedure was adapted according to the manufacturer’s instructions 
for the application of Optimaix 3D. With the “drop-on” and “dip-in” procedure, two 
different methods were available.[127] 
The Optimaix 3D is able to take up fluid that equals 97% of the total scaffold 
volume. This volume was added onto Optimaix 3D Sponge1 scaffolds in the drop-
on procedure. In contrast to that, scaffolds were immersed into a cell suspension 
for the dip-in procedure.[127] 
4.6.2 Fibrin and polyvinylidenfluoride (PVDF) 
Fibrin is the clotting factor I that is a systemic protein takes place in haemostatics 
processes.[128] Fibrinogen is a fibrin monomer and consists of subunits (Aα, Bβ, γ)2 
with a molecular weight of 338 kDa.[129,130] The structural setup of the molecule 
can be reduced to three components, depicted in Figure 14. Three subunits are 
straightly aligned and have a length of 450 ± 15 Å.[131] 
Figure 14 also shows fibrinogen polymerisation; where the D and E domains are 
bound by electrostatic interactions. Factor XIIIa leads to a covalent bonding of the 
fibrin monomers between D and E subunits, which is indicated with red connecting 
lines in Figure 14. Fibrinolysis results in single subunits, not to intact fibrinogen. 
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Figure 14: Structural setup of fibrinogen with its three subunits, 2D and 1E. 
Polymerisation and crosslinking of fibrinogen lead to a stable fibrin clot, while 
fibrinolysis results in single subunits.[6] 
The clotting process as illustrated in Figure 14 and Figure 15 is actually the end of 
a whole blood clotting cascade and fibrinolysis.  
Figure 15 shows both, the coagulation process and fibrinolysis. This overview 
illustrates the coagulation where prothrombin is converted to thrombin resulting in 
a fibrin clot. This clot is stabilised by factor XIIIa. The clot is the fibrinolysed. It can 
be seen in the figure that plasminogen is activated by the tissue plasminogen 
activator (tPA) or urokinase-type plasminogen activator (uPA), which results in the 
conversion to plasmin. Plasmin degrades fibrin clots at the binding sites of the D 
and E domains. This results in D-dimers and an E-subunit. However, competitive 
inhibition by tranexamic acid, antiplasmin or aprotinin can slow down this 
process.[128,130,132–135] 
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Figure 15: Simplified illustration of haemostasis that leads to natural blood 
clotting. Coagulation and fibrinolysis are schematised with focus on tissue 
engineering applications.[6,130,132–135] 
For the composite biohybrids, the stabilising material was polyvinylidenfluoride 
(PVDF; (CH2-CF2)n), which is a common material used in various (bio-) medical 
applications as scaffold material, mesh or suture. Its biocompatibility, chemical 
inertness, durability and the ability for surface modifications are appreciated for 
medical treatments.[136–139] 
The institute for textile technology of the RWTH Aachen University (ITA) provided 
the applied PVDF mesh (Trickot E30 EAC 10). This mesh was manufactured in a 
melt spinning process, which produces a multifilament yarn consisting of 16 single 
filaments and was knitted into a tubular shape. 
The PVDF mesh was sterilised by low temperature plasma sterilisation. In addition 
to sterility, this treatment leads to increased biocompatibility and surface tension. 
Thus, the adhesion of the applied fibrin and primary cell culture process can be 
improved.[140–142] 
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4.6.2.1 Fibrin preparation 
Fibrin preparation started with the dissolving of the lyophilised protein in purified 
water. To this end, fibrinogen and purified water were placed separately in an 
incubator at 37 °C for at least 1.5 hours. Subsequently, 39 mL of the preheated 
water was transferred in a vial containing 1000 mg fibrinogen. The dissolution took 
4-5 hours at 37 °C. 
In a second step, the fibrinogen solution was split up (313 mL) and was dialysed 
against (3) 4.5 L Tris-buffer (TBS) (see Chapter 4.3.1) overnight at room 
temperature. For this purpose, a cut-off membrane of 6000-8000 MW was 
used.[106,143,144] Thus, the TBS replaced the water. Sterile filtration was conducted 
prior to the determination of protein concentration by light spectrometry at 280 
nm.[106,143] 
The protein concentration was determined in a UV-VIS spectrophotometer in the 
ultra violet (UV) spectrum (<300 nm) using suitable cuvettes that do not absorb the 
UV-light.  
Generally, the absorption of UV-light is based on the defined energetic difference 
between two energy orbitals. Electrons in the ground state are not excited, but 
they can be brought into higher energy orbital due to incident photons with a 
specific energy. The absorption maximum of proteins at a wavelength of 280 nm is 
characteristic for aromatic rings that are exclusively represented in phenylalanine, 
tryptophan, histidine and tyrosine. Variations in the total amount of these amino 
acids cause little differences in specific absorption coefficients. Further differences 
are caused by the influence of the buffer solution, which interacts, with the tertiary 
structure of proteins. To avoid this, parameters like pH values or ionic strength 
were kept constant.[145] 
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(2) 
The Lambert Beer’s law correlates the absorbance of light with specific (here: 
protein) concentrations: 
 
𝑐⁡ [
𝑚𝑔
𝑚𝐿
] = ⁡
𝐴
𝜀 ∙ 𝑑
∙ µ 
c = concentration 
A = absorbance 
ε = absorption coefficient 
d = path length of light in the medium 
µ = dilution 
 
The specific absorption coefficient (ε) depends on the species and is given for 
human fibrinogen with a value of 1.55.[146] 
Subsequent to the measurements, a fibrinogen concentration of 12.5 mg mL-1 was 
prepared with sterile TBS. Aliquots were arranged and stored at -80 °C. 
For the prosthesis preparation, fibrinogen solution (50%), TBS with cells (35%), 
thrombin (40 U mL-1) (7.5%) and 50 mM CaCl2 (7.5%) were mixed with each other 
by means of a two-chamber applicator system.[106,143] 
4.6.2.2 PVDF mesh preparation 
Knitted PVDF meshes were cut into pieces of 9 cm length. Afterwards, these 
tubular segments were put onto Pasteur pipettes that had a diameter of 7 mm. 
They were then placed in an oven at 125 °C for 10 minutes. The meshes were 
washed with 99.9% ethanol and purified water for 15 minutes after a cooling phase 
at room temperature. They were dried in a laminar flow hood over night before 
plasma sterilisation was conducted at the RWTH Aachen University Hospital, 
Aachen.  
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4.7 The “UREPLACE” bioreactor system 
The basis for this study was developed by Denis Schehl (2011)[147] and Volker 
Seifarth (2011)[148] a bioreactor system was designed comprising a tubular bioreactor 
for tissue engineering purposes. The bioreactor was separated from the incubation 
system to have an easy usage. Figure 16 shows the bioreactor with its modular 
setup, designed for the cultivation and growing of tubular constructs. It is 
characterised by two independent media circuits with two small inlets for the outer 
medium flux and one central inlet for the luminal support. Its equivalent diagram is 
depicted in Figure 17. 
 
 
Figure 16: UREPLACE Bioreactor Prototype III.[149] 
In the two studies mentioned before it was possible to show that the application of 
HiTec Zang components was useful for the transfer of cell culture media and that the 
LabBox®2 (HiTec Zang) was a suitable interface for controlling and recordinging 
incubation parameters. First test series lead an optimal adjustment of the controllers 
for the temperature and CO2 fumigation system with respect to their step 
responses.[147,148] This means that the start-up process of the system was optimised 
to enable the setting of a specific temperature (37 °C) and CO2 concentration (5%). 
Besides that, a prototype of a rotary unit was integrated that was supposed to make 
a homogenous distribution of cells in a collagen scaffold (Optimaix 3D Sponge1) 
possible. It was able to sway the bioreactor with a rotation angle of 270°. The pH 
value of the medium which is pumped from a reservoir through the system to the 
waste reservoir determined the media flow rate. The more the pH differed from 7.4, 
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the faster was the cell culture medium transfer.[147,148] Besides that, a first prototype 
of a catheter based peristaltic stimulation[150,151] was further developed by 
implementing an automated expansion and deflation of the catheter to achieve a 
physiological stimulation. Subsequent to the expansion, the catheter was supposed 
be pulled through the lumen of the tubular structure, before being deflated and 
pushed back again.[147,148] 
Figure 17 schematises the setup for the application of the Bioreactor Prototype III. 
The unidirectional medium flow (M1, M2) was realised by peristaltic pumps (P1, P2) 
that were controlled by the measured pH value. Tubes and valves were connected to 
each other in such a way that both media circuits could be measured with one glass 
electrode. This electrode was washed with water in between the measurements. 
 
Figure 17: Schematic setup of the medium circulation in the Bioreactor Prototype III 
including peristaltic stimulation and PBS flushing to avoid contaminations.[147] 
An inlet for the catheter was realised by the component seen in Figure 18 (left). 
Phosphate-buffered-saline (PBS) is directed through the central fitting of the 
bioreactor during peristaltic stimulation. Thus, contaminations were avoided by 
flushing out contaminating particles. There was no sealed connection between 
catheter and bioreactor. A catheter was attached to a linear actuator for the 
movement of the catheter was realised by the component seen in Figure 18 (right). 
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(3) 
(5) 
(4) 
(6) 
 
Figure 18: Components developed for access of the embolectomy catheter to the 
bioreactor (left) and for connection of the catheter to the linear actuator (right).[147] 
 
4.8 Statistics 
Statistical analyses were performed with Microsoft Excel, LabVIEW and Gnu R, 
where: 
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n: number of data items 
𝑥𝑖: i
th value in the dataset 
 
Wilcoxon rank-sum test was used in Gnu R to determine significance. 
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5 Results and Discussion 
During this thesis, several adaptions and improvements were a result from a 
constant learning curve. They were implemented in the bioreactor and the 
bioreactor system to improve the cultivation of different cell types in tubular 
structures. Improvements with respect to component design prior to the presented 
experiments lead to significant optimisations of the system and the bioreactor.  
5.1 Adaptions to the “UREPLACE” bioreactor system 
5.1.1 The graphical user interface (GUI) 
HiTec Zang provided LabVision® and HiText™ as software packages that were 
used for customised control of laboratory equipment in combination with a 
LabBox®2. The panel configuration of the LabBox®2 was changed in comparison 
to (Schehl, 2011)[147]. A digital output was replaced by a digital input and two 
additional serial ports were added next to the BASCOM unit. The applied 
LabBox®2 served as interface between the actuators and sensors that were used 
for the bioreactor system. These actuators and sensors were driven and read out 
with LabVision® and HiText™. A graphical user interface (GUI) was designed in 
LabVision®. Preconfigured building blocks with predefined programs for the control 
of standard equipment, e.g. pH electrodes, allowed a fast and reliable setup of a 
user interface. Moreover, LabVision® was used to export all important measuring 
values as well as derived measurement values and parameters set by the 
operator. HiText™ was used in combination with LabVision® to code experimental 
sequences and monitoring systems. 
The graphical user interface that can be seen in Figure 19 was based on the first 
draft by D. Schehl (2011) and was improved by adding tab pages for an advanced 
surface structure. The tab pages enable a clear division into three sections: A) the 
start-up of the bioreactor system, B) the “functional” units and C) the monitoring of 
the current measuring values.  
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Figure 19: Improvement of the graphical user interface by a separation into a A) start-up, B) “functional” and C) monitoring section.[6] 
   
A) B) C) 
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Controlling and calibration units, e.g. temperature and pH electrodes, were 
arranged on tab pages, which resulted in fewer elements on the GUI even though 
elements were added. In addition to the previous version, a pH calibration unit 
(“pH-Kalibration”), a pump unit (“Pumpen”) that was separated from the 
“Mediumzirkulation” and a tube-filling unit (“Schlauchs.”) were added for easier 
start-up and control of the system. A pH calibration unit became necessary due to 
new pH electrodes that needed to be calibrated regularly. 
The “functional” tabs were still placed in the centre of the interface to underline the 
importance of these elements. Instead of providing access to all functions on the 
page, which only required on click but made the surface appear confusing, the 
division into three sections still enabled direct access but also provided a much 
more structured surface. On the functional’s unit tab a time panel was integrated 
that displayed the elapsed time for the active medium circulation system. 
Extra information was added to the diagrams for monitoring the most important 
parameters. Current measurement value displays were added for the temperature 
in the incubator and the medium reservoirs, the CO2 concentration, the pH values 
of the cell culture media and the pressure in the catheter pressure line.  
All in all, the surface structure became clearer due to three defined sections 
so that the operating of the bioreactor system was improved further. The use 
of the system became intuitive, and even inexperienced operators to use the 
graphical user interface without much practice. 
5.1.2 Redesign of the inputs and outputs of Prototype III 
Further achievements were added to the bioreactor design. This design regarded 
new requirements resulting from e.g. cell seeding procedures. Figure 20 gives an 
overview of the different parts of the advanced bioreactor system. Prototype IV is 
presented there with several improvements compared Prototype III. 
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Figure 20: Bioreactor Prototype IV with angled medium inlets and outlets at the 
improved front plate (1) and piston (2), advanced central fittings (3) and fittings for 
the medium flow (4) covered in a glass cylinder (5) with a stainless steel housing 
(6), (7) and sealed with O-rings (8), (9) and (10).[6] 
The redesign of the medium supply for the outer circuit was realised by increasing 
the diameters of the boreholes in front plate and piston from 2 mm to 4 mm. At the 
same time, the number of boreholes was reduced to one. Thus, fewer tubes and 
fewer tube-connectors resulted in improved handling.  
Furthermore, angled inlets and outlets for the cell culture medium lead to fewer air 
bubbles inside the bioreactor compared to Prototype III. Nevertheless, except for 
the application in the rotatory unit, it needed to be ensured that the medium outlet 
was directed upwards. The bioreactor itself was still horizontally adjusted like in 
Figure 20. Thus, an air bubble trap like in other systems became 
dispensable.[67,152,153] 
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A further development can be seen regarding the sealing of the piston: the number 
of O-rings was reduced to one. As a consequence, it became much easier to 
insert and move the piston inside the glass cylinder. The distance between the 
central fittings could be adjusted more smoothly and the system stayed still without 
leakage. 
Another improvements were the redesigned central fittings, on to which the 
scaffold material was placed. The previous Prototype III had fixed fittings at the 
front plate and at the piston with fixed dimensions. For the dip-in seeding 
procedure of cells in combination with the Optimaix 3D Sponge1 as scaffold 
material, it became necessary to detach the fittings. Screwable fittings were 
enabled to be attached to the front plate or the piston after an immersion of the 
scaffold in cell suspension. To achieve this, additional threaded boreholes were 
prepared at the attachment sites. These boreholes had the advantage that 
different types of fittings with different dimensions could be used in this 
Prototype IV. 
The modular setup makes the bioreactor flexible and easy to handle. This 
results in cost effectiveness, which is an important factor in making bioreactor 
suitable for clinical application.[58,59,154] 
The material of the redesigned parts (front plate, piston and fittings) was 
polyoxymethylene (POM), an inert plastic material with suitable characteristics for 
cell culture technologies. This material can be sterilised by autoclaving, shows a 
high biocompatibility and cells do not attach to it.[155] 
All these parts were manufactured according to prepared technical drawings (see 
Chapter 8.3) in the workshop of the Aachen, University of Applied Sciences in 
Jülich.  
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5.1.3 Improvement of the central fittings 
The redesigned central fittings for the fixation of the scaffold materials were a 
significant improvement that became necessary for the application of the Optimaix 
3D Sponge1 as well as for the subsequent application of fibrin-based scaffolds. 
Figure 21 shows two different fitting configurations that were used in this study. 
These fittings provided a screw thread (M10) that could be attached to the front 
plate and piston of the bioreactor. A hexagon key was used to tighten the fitting. 
The opposite side of the fittings was characterised by smoothly rounded edges to 
reduce mechanical stress on the biohybrids.  
 
 
Figure 21: Central fittings for the application of Optimaix 3D Sponge1 and 
untrained fibrin-based prostheses A). And B) for the use in combination with 
trained prostheses in Bioreactor Prototype IV.[6] 
The fitting design in Figure 21 A) was used for untrained Optimaix 3D Sponge1 
and fibrin-based prostheses. This fitting was used for completely independent 
media circuits.  
Cable ties were taken for both fitting configurations to fix the scaffold materials. A 
tight and reliable immobilisation was achieved in combination with two small barbs 
 
 
 A) 
B) 
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(0.5 mm) that were added to these fittings. Moreover, it can be seen in Figure 
21 B) that there was an additional notch (red rectangle), which was used as a seat 
for an O-ring. This O-ring was required for the use in the fibrin casting mould 
explained in Chapter 5.6.2.2 to avoid leakage. Dimensions of the notches were 
adapted to the diameter of the O-rings that were applied. Specialised table books 
gave a slot width of 2 mm and a depth of 1.1 mm.[156] 
Configuration B) (Figure 21) was used exclusively for trained, fibrin-based 
prostheses. The reason for that was the missing central medium supply, because 
of the peristaltic stimulation that was performed with a kyphoplasty balloon 
catheter. Hence, the catheter needed to ensure the inner medium circulation. The 
catheter occluded the prosthesis and acted as a piston. Figure 22 illustrates the 
medium flux in stimulated fibrin-based biohybrids due to a moving balloon 
catheter. Cell culture medium was drawn through a borehole (red hexagon) in the 
fittings. This is a result of the lower pressure that is caused by the moving catheter 
(p1 < p2). On the other side of the balloon, excessive cell culture medium was 
pressed through the fitting. Consequently, there was a constant medium exchange 
in the lumen of the construct ensured by fresh medium from the outer medium 
circuit. 
 
 
Figure 22: Schematic illustration of the inner medium circulation caused by 
mechanical stimulation with a balloon catheter. The movement of the catheter 
leads to a volume displacement, resulting in a medium transfer.[6] 
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5.1.4 The circulation of cell culture medium 
The circulation of the cell culture medium was completely redesigned with a closed 
loop structure that ensured a contamination-free operation of the bioreactor 
system. 
Figure 23 shows a scheme of the cell culture medium circulation for the bioreactor 
prototype IV. It can be seen that the medium circulations are separated from each 
other. 
 
 
 
Figure 23: Flow chart of the redesigned medium circulation with a closed loop 
structure and separated circuits. Each circulation has its own reservoir, peristaltic 
pump and pH electrode.[6] 
In this study, the closed loop structure was based on new medium reservoirs that 
were equipped with multifunctional customised lids (Bola). Screw caps for 
standard GLS 80 glass bottles (Schott Duran) were manufactured according to the 
requirements. They were sterilisable with damp heat and provided with: 
 an inlet for a pH electrolyte electrode (Schott) with a PG 13.5 thread 
 a tube inlet and outlet 
 an opening for gas exchange 
 a septum (VWR) for regular sampling 
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Figure 24: Customised GLS 80 screw cap made out of PTFE with 1PG 13.5 for a 
pH electrode, 1M141.5 for the integration of a septum and 3NTP¼” for a cell 
culture medium inlet and outlet and for gas exchange.[6] 
Figure 24 shows the screw cap developed to seal the medium reservoirs. The 
materials were polytetrafluorethylene (PTFE) and polyphenylene sulphide (PPS) 
so that it became possible to sterilised the caps by autoclaving at 121 °C and 2 
bars.  
The screw caps were equipped with openings for pH electrodes (1PG 13.5), 
tubes and gas exchange (3NTP¼”) and a septum (1M141.5). 
The opening for the gas exchange at the screw cap was connected to an 
additional silicone tube and a sterile filter. Synthetic materials are gas 
permeable[157], but an additional opening to the atmosphere was provided to allow 
gas exchange. Medium that was transferred into the bioreactor was taken from the 
bottom of the reservoir that was filled with 550 mL of medium III (see 
Chapter 4.4.2) for fibrin-based prostheses. Medium II was chosen for collagen-
based biohybrids. Returning cell culture medium dropped into the reservoir from a 
distance of about 5 cm above the fluid level. This ensures a homogenous cell 
culture medium circulation inside the whole system. 
The medium quality was monitored with a gel electrolyte electrode that was 
sterilisable compared to standard glass electrodes that contain a standard 3 M KCl 
electrolyte.[158] Cell culture medium starts to get acidic during cultivation. Moreover, 
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the pH shows a metabolic lapse in case of a contamination. The applied pH 
electrode was equipped with a temperature sensor and attached to the LabBox®2 
(HiTec Zang) to monitor and record the measured pH values. LabVision® provided 
a software component for the integration and calibration of the pH electrode. This 
made it possible to consider the current temperature in the calculation of the pH 
value (see Chapter 4.4.1.1). 
The risk of a contamination during sampling was minimised by considering a place 
for an exchangeable septum instead of the T-connectors widely used as a 
“standard setup”, because the surface that was susceptible was much smaller in 
such a septum. Another factor minimising the risk was the use of fewer 
components, further reducing the number of surfaces that can be 
contaminated.[63,159] Sterile syringes and needles were used to extract medium 
samples that may be used for further analysis. 
The presented closed loop structure (see Figure 23) had the further advantage 
that no cell culture medium was wasted. During cultivation processes, the medium 
was changed regularly after 4-7 days. Moreover, there was no opening in the loop, 
which could lead to a contamination of the experimental setup. In this case, 
previous developments[147,150,151] had shown deficiencies. Additionally, the applied 
pH electrodes were not sterilisable.  
During operation, the new medium circuit proved to be high reliable and 
sterile during application. More than 10 experiments were performed in 
combination with the Optimaix 3D Sponge1 without using antibiotics and no 
contaminations were observed. Even the first fibrin-based prostheses were applied 
without antibiotics. In literature it can be seen that similar medium circuits[153,160] 
were used, but they used antibiotics that was required by their system. 
Peristaltic pump heads arranged in parallel, which were used in this study, allowed 
simultaneous operation of two bioreactors. This is an additional advantage with 
respect to a cost-effective operation of the tubular bioreactor system in a clinical 
setting.  
The pump heads were combined with Marprene tubes and their flow rate was 
determined by the evaluation of the mass transfer of water in 30 minutes at a 
velocity of 20 rpms. Tubes were put into the pump heads one night prior to this 
investigation, so that the tubes could adapt to the pump. The mass transfer 
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amounted to 502 mL in 29.5 minutes. At 10 rpm, a general cell culture medium 
transfer rate of 8.6 mL min-1 was determined by the rule of proportion. 
Additionally, single hand quick connectors were used to exchange the medium 
reservoirs faster. Thus two electrodes were necessary for one bioreactor. In this 
study, just two electrodes were connected to the LabBox®2. Consequently, this 
procedure was only possible in case of a single bioreactor application within the 
system. 
A software (HiText™) was used to code an automatised program for the transfer 
of cell culture medium into the bioreactor system. A master program checked 
which medium circuit was selected on the graphical user interface. According to 
that, three subroutines were prepared for the control of medium circuit 1, 2 or both. 
The start-up and shut-down of the used peristaltic pumps were realised by an 
increasing or reducing of the pump head velocity with 0.5 rpm s-1. This ensured a 
slow development of the flow rate. 
All adaptions and improvements to Prototype III were performed to minimise 
outside influences, e.g. temperature decrease, unsuitable pH values or cell 
culture medium depletion. 
Reducing negative outside influences, as shown for Prototype IV, and mimicking a 
natural surrounding as completely as possible increase the chance for successful 
tissue generation.[161,162] 
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5.2 Peristaltic stimulation 
5.2.1 Catheters, pressure lines and sterility 
Literature shows that mechanical stimulation of tubular constructs is based on 
pulsatile fluid flows that are generated by peristaltic pumps.[163–166] Moreover, it 
becomes apparent that the engineering of tubular tissue is mostly confined to 
vascular grafts.[163–166] 
However, in this study several improvements were performed with respect to the 
design of the tools and components that were necessary for a physiologic 
peristaltic stimulation. Basic ideas from [147,148,150,151] that were presented in 
Chapter 4.7 were considered and served as a template for the new mechanical 
stimulation procedure. 
A balloon catheter was used for the mechanical stimulation of the tubular, fibrin-
based biohybrids (see Figure 22). This was done to achieve a local stimulation of 
the used primary smooth muscle cells that were isolated from porcine bladders 
(see Chapter 4.4.5). It was possible to show that the applied embolectomy 
catheter provided with a flexible guide wire, that was used by [147,150,151], was not 
useful for further application. This guide wire was unsuitable for the forwarding of 
the catheter. The distance between the attachment point at the linear actuator and 
the access to the bioreactor (see Figure 18) was so long that it lead to a sagging 
of the guide wire. In some cases, this resulted in curls in the wire due to the 
compression, when the catheter was pushed in toward the bioreactor. Additionally, 
it turned out that the balloon at the tip was too fragile. This balloon consisted of a 
thin layer of silicone. New requirements specifying a rigid guidance and a 
suitable balloon material were defined. 
A kyphoplasty balloon catheter (Allevo Joline) showed the most suitable 
characteristics with a rigid guidance and a strong balloon made out of 
polyurethane. Normally, these catheters are applied for the reconstruction of 
vertebras, so that the balloons are extremely robust.[167–169] 
The system for the inflation of the catheter was redesigned. Inflation of the 
catheter was reproducible with a peristaltic pump[147,148], but the period of time was 
long (about 20 seconds). Moreover when, peristaltic pumps were used, the 
catheter was filled in a pulsatile manner, which was not desired. A syringe pump 
replaced the peristaltic pump to achieve a constant, highly precise, accurate and 
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fast filling of the catheter (7.2-19.2 seconds for 150-400 µL). Nevertheless, the 
speed can be increased further.  
The SyrDos syringe pump was operated with a stepper motor, where the volume 
of the attached syringe was divided into 48,000 single steps. For the 
characterisation, a HiText™ program was coded to transfer 1 mL of water. Then, a 
1 mL syringe was attached to the pump and the transferred volume was 
determined by weighing three samples with an analytical scale. It was assumed 
that water has a density of 1 g cm-3. Table 10 shows the results of the weighing 
procedure.  
 
Table 10: Evaluation of the volume transferred by the SyrDos with 1 mL syringe 
cylinder attached. 
Trial [n] Weight [g] 
1 0.9936 
2 0.9946 
3 0.9938 
  
The average volume transferred was 0.994 mL. Thus, the deviation from the 
desired volume was 0.6% (0.006 mL). 
Figure 25 illustrates the pressure line for the inflation of the kyphoplasty balloon 
catheter. Central elements were a syringe pump, a pressure sensor, a reservoir 
and a kyphoplasty catheter. Accessory parts, like connectors, adapters for the 
LUER connection, fittings etc. were obtained from the BESTA-Technik GmbH and 
matched the chosen tube material. The tube or capillary for the connection of the 
components was gained from an HPLC starter kit and had an inner diameter of 0.5 
mm. This tube was chosen because of its pressure resistance, and small inner 
diameter and volume.  
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Figure 25: Pressure line (red arrows) with a SyrDos syringe pump (green) for the 
deflation of a balloon catheter (black). A reservoir (yellow), filled with distilled 
water, was attached to a pressure sensor (blue) and to the pressure line.[6] 
Prior to each experiment, the water used to expand the catheter was degased and 
the pressure line was flushed several times to remove air bubbles. Flushing and 
filling of the pressure line was managed via program (“Schlauchs.”) that was 
integrated in the graphical user interface (see Chapter 5.1.1). 
To characterise and map the deflation of the catheter, a HiText™ program was 
written. This was necessary to determine the diameter of the catheter required for 
different filling volumes that were added by the SyrDos. The pressure was 
evaluated in the pressure line. Two laser sensors were added that determined the 
diameter of the balloon catheter. The transparent catheter was made visible for the 
laser sensors with talcum powder. The distance of the sensors to the balloon was 
determined by triangulation methods. Figure 26 shows the measurement setup 
that was developed in the lab for cell biophysics at the Aachen, University of 
Applied Sciences. 
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Figure 26: Measurement of the catheter diameter (red circle) with two laser 
sensors by means of laser triangulation.[6] 
 
Figure 27 illustrates the development of the shape of the balloon during the filling 
procedure from left to right. It can be seen, the more volume was added, the more 
spherical the balloon became.  
 
 
Figure 27: Filling process of a kyphoplasty balloon catheter. The diameter of the 
(blue) pole is 3 mm.[6] 
 
Sensor 1 
Sensor 2 
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(7) 
(8) 
The catheter was expanded gradually in steps of 20 µL to reach 300 µL (n=4). 
Diameters were read out from the Keyence user interface. Figure 28 shows a 
nonlinear dependence between the filling volume and the pressure in the PEEK 
tube system from the expansion and deflation of the catheter that was used for the 
peristaltic stimulation of tubular tissue matrices. The pressure is related to different 
catheter filling volumes. 
Figure 29 illustrates the catheter filling volume versus to the measured balloon 
diameter. The line of best-fit was determined to be a straight line with: 
 
𝑏𝑎𝑙𝑙𝑜𝑜𝑛⁡𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟⁡[𝑚𝑚] ⁡= 0.0107𝑥 + 5.5938 
 
and a correlation coefficient (r2) of 0.995. 
The dependence on the expansion and the resulting stress on the prostheses 
were based on a luminal diameter of 6 mm, which was the same for collagen and 
fibrin-based prostheses. The following equation was used to determine the applied 
strain: 
 
𝑠𝑡𝑟𝑎𝑖𝑛⁡[%] =
𝑥𝑖 ⁡− ⁡𝑑𝑖
𝑑𝑖
∙ 100 
with: 
di: luminal diameter (6 mm) 
xi: measured catheter diameter [mm] 
 
In this study, a mechanical stress level of 20% was applied to all fibrin-based 
biohybrids. Regarding the relation between the catheter filling volume and 
diameter, a volume of 150 µL was required. The program with the syringe pump 
achieved 150 µL as catheter filling volume. Further, there was a radially directed 
reduction of the strain level, due to the thickness of the prostheses. Thus, the 
strain was reduced by 3.3%, when the diameter increased by 1 mm. 
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Figure 28: Catheter filling volume vs. pressure in the tube system for the 
expansion and deflation of the catheter.[6] 
 
Figure 29: Catheter filling volume vs. diameter and strain. The basic luminal 
diameter of the prostheses was 6 mm.[6] 
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An improved component was used to ensure sterile access of the catheter to the 
bioreactor system and was called “contamination guard”. Figure 30 shows the 
contamination guard that was attached by a silicone tube to the bioreactor’s piston 
(see Figure 20). The distance between the bioreactor and the contamination guard 
was kept as short as possible. 
 
 
 
Figure 30: “Contamination guard” for sterile access of the kyphoplasty balloon 
catheter to the bioreactor, consisting of a septum (3) and two clamping 
components (1) and (2).[6] 
This contamination guard consisted of a PTFE-silicone-PTFE septum (3) and two 
components (1) and (2) that were screwed together. The septum had a central 
hole of 2 mm that was stamped and that allowed the catheter to be introduced and 
slide smoothly. The hexagonal shape of components (1) and (2) allowed easy 
assembling and disassembling with a screw-wrench. These two parts clamped the 
septum tightly.  
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The whole bioreactor, the medium circulation and the inlet for the kyphoplasty 
balloon catheter provide a completely sealed and leakage-free system. This 
contamination guard had the advantage that there was no opening to the 
bioreactor. In comparison to the unit using PBS flushing for the removal of 
contaminants (see Chapter 4.7) it was more save, because there was no need to 
remove contaminating particles. Cost effectiveness was increased, because there 
was no PBS needed during the stimulation, which removed contaminating 
particles. Moreover, it was possible to reduce the application of antibiotics. Test 
series revealed that an antibiotic-free application of the bioreactor was 
successful. 
In literature, there was no similar device was found. This is due to the novelty of 
the system that is presented in this study. A further improvement of this device 
could be achieved by adding a thread to the contamination guard and the piston at 
the bioreactor, leading to an enhanced, shorter and a stable connection. 
Another important component for the presented mechanical stimulation/training is 
a linear actuator, which moves the catheter forward and backwards. Figure 31 
depicts the linear actuator (1) that was attached to an engine mount (2), which was 
fixed with a base plate (3) in the incubator.[147,148] It was improved including 
modified with additional components (4) and (5) for the fixation of the kyphoplasty 
catheter. A covering plate above the stepping motor allowed additional guidance of 
the catheter and avoided a sticking/clamping of the catheter at the engine mount. 
Moreover, a bar (6) was attached and provided with a limit switch (not depicted) to 
calibrate the home position for the linear actuator. This device is important for 
regular calibration during the application. 
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Figure 31: A linear actuator (1) was attached to an engine mount (2) on a base 
plate (3).[147] The kyphoplasty catheter was fixed with a clamping arrangement (4) 
and (5) that was attached to the linear actuator. A bar (6) was used for the 
installation of a limit switch and a covering plate (7) as an additional supporting 
area for the catheter.[6] 
5.2.2 Software 
The software that was used for the peristaltic stimulation was coded in HiText™ 
and consisted of a master program (“Peristaltik”) and 6 subroutines.  
Routine sequences in the master program controlled the linear actuator and 
catheter expansion as well as the calibration steps. The program began with a 
start-up, activating subroutines, bringing the linear actuator and the catheter into 
the starting conditions. The catheter was driven slowly with 0.2 mm s-1 into the 
home position and the catheter was deflated gradually in steps of 20 µL, resulting 
in neutral pressure in the pressure line. 
Next, the catheter was moved forward by the distance and with the velocity that 
were adjusted on the graphical user interface (see Chapter 5.1.1). The path length 
was 45 mm and the velocity was 2.5 mm s-1 for fibrin-based prostheses. 
Subsequently, the catheter was expanded following a sigmoidal filling capacity.
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(9) 
𝑓𝑖𝑙𝑙𝑖𝑛𝑔⁡𝑣𝑜𝑙𝑢𝑚𝑒⁡[µ𝐿] =
𝐺
1+𝑒
−𝑘∙𝐺∙(( ∆𝑡86400)−𝐶
 
 
G: maximal filling volume [µL] 
k: slope 
C: day of the turning point [d] 
Δt: duration of the peristaltic stimulation [s] 
 
A sigmoidal adaption of the catheter filling volume lead to a slow increase of the 
exerted mechanical stress on the prostheses. In any experiment with a peristaltic 
stimulation, the slope (k) was set to 0.005, the inflection point to the third day and 
the maximal filling volume to 150 µL, which corresponds to a strain of 20%. Figure 
32 shows the relation of the catheter filling volume from the time of incubation and 
the resulting diameter of the kyphoplasty balloon catheter. This diameter lead to 
specific mechanical strains for prostheses with an initial diameter of 6 mm. 
 
 
Figure 32: Sigmoidal filling of the kyphoplasty catheter followed during incubation. 
It results in a maximum diameter of 7.2 mm and 20% strain.[6] 
Subroutines were also used to monitor the system. In case of failure, e.g. 
pressures exceeding 8 bar or a delay time of more than 20 minutes, an emergency 
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sequence was initiated. Then, the catheter was deflated gradually in steps of 
20 µL until neutral pressure was reached and was driven into the starting position. 
The procedure was similar to the start-up sequence. Subsequently, it became 
possible to begin the routine sequence again to continue mechanical conditioning. 
Regular calibrations were performed in the course of incubation, where the 
pressure line and the position of the linear actuator were adjusted to intervals of 20 
stimulations. In the end, a mean stimulation frequency of 0.015 Hz was achieved 
for mechanically stimulated fibrin-based prostheses. Figure 33 shows a sample of 
a mechanical stressed prosthesis, where a kyphoplasty catheter was pulled 
through the lumen of the tubular structure. It can be seen that the stimulation lead 
to a weak ablation of fibrin at the contact surface. Nevertheless, this did not result 
in a separation of the fibrin-matrix and PVDF mesh or in a negative influence for 
surrounding cells.  
 
Figure 33: Luminal surface of a fibrin-based prosthesis that was stimulated for 1 
week with a kyphoplasty catheter.[6] 
 
5.2.3 First test series 
First tests on the catheter in combination with cells were done with an established 
cell line (C2C12 myoblasts), primary smooth muscle cells and the Optimaix 3D 
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Sponge1. Additionally, a combination with fibrin and Optimaix 3D Sponge1 was 
tested. 
 
Table 11 summarizes the experimental parameters and differences with respect to 
cell types, fibrin applications and durations of the experiments and the resulting 
quantity of stimulations. Control samples were treated equally to mechanically 
stressed (trained) biohybrids disregarding the application of the catheter. 
 
Table 11: Experimental setup to test a mechanical stimulation with a kyphoplasty 
catheter. An established cell line (C2C12) and primary smooth muscle cells were 
applied on the Optimaix 3D Sponge1 with and without fibrin. 
Experiment Cellcount Duration 
Cell culture 
medium (see 
Chapter 4.4.2) 
Fibrin + SMCs + 
Optimaix 3D Sponge1 
5000 cells µL-1 
in 1 mL 
6 days 17 hours/ 
8057 stimulations 
medium III  
C2C12 + Optimaix 3D 
Sponge1 
5000 cells µL-1 
in 1 mL 
9 days 18 hours/ 
18069 stimulations 
medium II  
 
Optimaix 3D sponge1 fragments with a length of 1 cm were seeded with 1 mL cell 
suspension using the drop-on procedure (see Chapter 4.6.1.1). On each sample, 
5106 cells were applied. Primary smooth muscle cells were seeded with fibrin to 
fix the cells inside the sponge matrix. The application of fibrin is explained in 
Chapter 4.6.2.1. 
Figure 34 shows the experimental setup based on a Schott Duran bottle (GL 45). It 
was equipped with the contamination guard to introduce the catheter into the bottle 
that contained cell culture medium II or III (80 mL). Additionally, there was a 
silicone tube covered with a sterile filter to allow gas exchange with the ambient air 
in the incubator. 
The catheter was introduced into the bottle and the seeded scaffolds were placed 
at the catheter tip before the periodical expansion and deflation started. In this 
experiment, the catheter was expanded to about 10 mm with a filling volume of 
400 µL. It was not moved throughout the seeded collagen scaffold. Thus, 
mechanical stress was applied exclusively in circular direction. The whole setup 
was placed inside the incubator at 37 °C and 5% CO2. 
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Figure 34: Experimental setup for the application of circular mechanical stress on 
cells that were seeded onto the Optimaix 3D Sponge1 (blue). A kyphoplasty 
catheter was introduced into a glass bottle which the screw cap was equipped with 
the contamination guard (yellow) and an opening to the outside (green).[6] 
Samples were fixed in Carnoy’s fluid and prepared for further histological analysis 
(see Chapter 4.5). Scanning electron microscopic pictures were prepared to 
analyse the effect of the mechanical stimulation on cellular orientation. 
The following scanning electron microscopic pictures (Figure 35 and Figure 36) 
indicate the effect on circularly stretched tubular structures that were seeded with 
different cell types. Figure 35 A) and Figure 36 A) show unstimulated (untrained) 
samples i.e. samples that were not exposed to mechanical stress (training). 
Primary smooth muscle cells (Figure 35 A)) and C2C12 myoblasts (Figure 36 A)) 
were distributed homogeneously on the outer surface of the tubular, sponge-like 
collagen scaffold. In contrast to that, it can be seen in Figure 35 B) and Figure 
36 B) that the cells preferred a certain orientation. In both cases, this orientation 
was circular around the tubular structure. These results are comparable to [74,80], 
where the stretching of a three dimensional structure lead to a cellular 
orientation towards the applied strain. 
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Figure 35: Scanning electron microscopic pictures of mechanically unstimulated 
A) and stimulated B) porcine primary smooth muscle cells that were seeded onto 
the Optimaix 3D Sponge1.[6] 
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Figure 36: Scanning electron microscopic pictures of mechanically unstimulated 
A) and stimulated B) C2C12 myoblasts that were seeded onto the Optimaix 3D 
Sponge1.[6] 
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5.3 Long-term stability of the bioreactor system  
Long-term stability of the bioreactor system was monitored during the use of 
Bioreactor Prototype IV for 1 week (n=4) and for 2 weeks (n=4). The incubation 
system was started prior to cell seeding (see Chapter 0) and was initiated at the 
same time as temperature and CO2 system. Both were part of the start-up section 
(see Chapter 5.1.1) displayed on the graphical user interface. 
All data were recorded with 1 Hz from the beginning of the experiment and 
exported in comma-separated values (CSV) at the end of the incubation phase. 
Table 12 shows the results of the evaluation as mean values with their standard 
deviation (SD). Additionally, the deviation is given in %. 
 
Table 12: Evaluation of the incubation parameters in long-term experiments for 
1 week (n=4) and 2 weeks (n=4) for the application of Prototype IV in the 
incubation system, with SD = standard deviation. 
 1 week 2 weeks 
Mean SD Deviation 
[%] 
Mean SD Deviation 
[%] 
Temperature in the 
incubator [°C] 
37.0 0.2 0.4 36.9 0.9 2.4 
Temperature in the 
medium [°C] 
36.9 0.2 0.6 36.9 0.7 1.8 
pH in the cell culture 
medium 
7.5 0.3 3.4 7.6 0.2 3.2 
CO2 [%] 5.0 0.3 6.0 5.0 0.30 6.0 
 
It can be concluded that the incubation system was working reliably. The 
temperature inside the incubator and media reservoirs were nearly identical and 
differed from the nominal value (37 °C) by less than 1 °C (≤ 2.4%). This was 
caused by the fact that the media reservoirs were placed inside the incubator. All 
sensors (Pt100) were calibrated at the same time and showed just little variations. 
Greater temperature differences in experiments lasting 2 weeks were caused by a 
maloperation. In a single case, the temperature dropped subsequently to a 
planned exchange of medium reservoirs. A telemetric alert sent by the system via 
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e-mail or short message could be used in the future to avoid such incidents. 
LabVision® is able to detect if parameters deviate from a defined range. In 
emergency cases, the system could contact the operator. 
Furthermore, pH values were kept in the range of 7.4 with deviations of less than 
3.4%. This range could be narrowed in the future by using new electrodes that 
have a shorter response time. 
CO2 concentrations were in the range of 5.0 ± 0.3 in all experiments. A 6% 
deviation happened as the daily sampling was performed. Sampling involved 
opening the incubator completely, which changed the 5% CO2 concentration and 
consequently lead to greater standard deviations. Nevertheless, it could be shown 
that the correction time required to get back to 5% was in the range of 10 
minutes.[148] 
Besides that, all other programs (mechanical stimulation, cellular distribution or the 
start-up of the system) were functioning properly.  
 
5.4 Rotation unit and cellular distribution 
To distribute seeded cells homogeneously, it was required that the bioreactor was 
swayed around its longitudinal axis. The rotation unit[147] was redesigned to enable 
increased rotation angles from 270° to 380°.  
Figure 37 depicts the rotation unit with an attached bioreactor is attached. The 
support (blue) was connected to a stepper motor. This bearing was an 
improvement to the previous version because it made operation more comfortable. 
It became easier to place the bioreactor into this unit, even when tubes were 
connected. Additionally, the increased bearing area lead to a more stable fixation 
of the bioreactor. 
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Figure 37: Redesigned rotation unit with an improved bearing for a homogeneous 
distribution of cells on Optimaix 3D Sponge1 scaffolds.[6] 
It was possible to demonstrate that this rotation unit lead to a homogeneous 
distribution of applied cells. Figure 38 shows a DAPI staining photographed with a 
fluorescence microscope. NIH-3T3 fibroblasts were applied on the Optimaix 3D 
Sponge1 scaffolds and incubated for 21 days. This incubation process resulted in 
a circular, homogeneous distribution of the cells on the outer surface of the 
scaffold material. 
 
 
Figure 38: DAPI staining of NIH-3T3 fibroblasts applied on Optimaix 3D Sponge1 
and incubated for 21 days.[6] 
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5.5 Isolation and cultivation of primary smooth muscle cells 
The isolation of primary smooth muscle cells was performed according to the 
protocol that was described in Chapter 4.4.5. This protocol was applied for all 
fibrin-based tubular constructs. Prepared T75 cell culture flasks were put into the 
cell culture incubator at 37 °C, 5% CO2 and 100% humidity and were not moved 
for a week. Thus, tissue fragments were not displaced, resulting in less stress and 
violent detachment of cells. Cells grew out of tissue fragments and attached to the 
cell culture flasks. After 1 week, cell culture medium I was replaced by cell culture 
medium II, which did not contain antibiotics (see Chapter 4.4.2). After that, the cell 
culture medium was changed regularly every 4 to 5 days. 
Cell clusters grew circularly and got denser in their centre. When these centres 
started to get necrotic and when contact inhibition started, the cells were sub-
cultivated to reduce cellular density. For fibrin-based experiments, cells were 
passaged into T175 flasks in passage 1 and into T500 flasks in passage 2. 
Passage 3 was 7 times used and passage 5 only once for preparation of fibrin-
based prostheses (n=8). 
Viability of the cells was determined with a BioRad cell counter TC20™. Mean cell 
viability was determined to be 97% and the average time from cell isolation 
to the application in a prosthesis was 57 ± 17 days. 
Cell viability was greater than 90% in all cases, which shows the cells were treated 
gently and compliant to the rules of cell culture technologies. Nevertheless, it 
became apparent that the proliferation of the cells isolated from different pigs 
differed, which resulted in preparation periods in the range of 1 to 2 months. This 
period of time was required from the isolation of the cells to the application in the 
Bioreactor Prototype IV in order to achieve high initial cell counts in the biohybrids. 
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5.6 Scaffold materials – application and characterisation 
5.6.1 Optimaix 3D Sponge1 
Optimaix 3D Sponge1 was analysed with respect to its biocompatibility, pore sizes 
and suitability for cell culture application. To achieve that, different cell types (NIH 
3T3 fibroblast, Urotsa, C2C12) were applied on the scaffold with varying seeding 
procedures. Co-cultivations were tested, using C2C12 myoblasts and Urotsa cells. 
Both proved the bioreactors performance and suitability. Pore sizes were analysed 
by means of scanning electron microscopy and a specially coded LabVIEW 
program that measures pores randomly selected by the operator. 
In addition to the results presented in Chapter 4.6.1, it could be shown, that tubular 
Optimaix 3D Sponge1 behaves similar to planar Optimaix 3D. To test that, 
Optimaix 3D was implanted into the porcine bladder wall, between the serosa and 
the smooth muscle. Test animals were sacrificed after 12, 16 and 26 weeks and 
were inter-individually compared. The results showed decreasing amounts of 
intact collagen scaffold between 12 and 16 weeks and after 26 weeks there was 
no scaffold detectable. Due to the fact, that there were no negative side effects 
e.g. inflammation or encapsulation, it was concluded that this configuration is 
biocompatible in vivo in pigs, too. 
5.6.1.1 Optimaix 3D Sponge1 dimensions 
For scanning electron microscopy, collagen scaffolds were cut into sections as 
depicted in Figure 39. Scaffolds were cut with microtome blades (Feather), which 
allowed to prepare adequate cutting areas. The use of scissors and scalpels had 
lead to squeezed materials and surfaces, which rendered the sample useless. The 
analysed fragments had a thickness of about 1-2 mm and were fixed on specimen 
mounts. Pore sizes were measured on the outer surface (n=4) and inner matrix. 
To analyse pores inside the sponge, two additional sections were prepared: the 
modified surfaces (n=3), where just the top (outer) layers were removed, and 
central surfaces (n=4) in the middle of the collagen sponge. Besides that, samples 
were set showing the luminal surface (n=3).  
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Figure 39: Schematic illustration of prepared sections for the scanning electron 
microscope to determine pore sizes. Different colours code for different surface 
positions that were analysed.[6] 
A LabVIEW program was designed, which was able to load scanning electron 
microscopic pictures and enabled the definition of regions of interest (n=20) by 
hand of the operator. The program analysed the size of encircled particles or 
pores. The data were exported as a cross-sectional surface area into an EXCEL 
sheet and statistically analysed. Figure 40 and Table 13 summarize pore sizes on 
and in Optimaix 3D Sponge1. 
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Figure 40: Evaluation of pore sizes of Optimaix 3D Sponge1. Colours correspond 
to Figure 39. Differences between any two groups are significant (p<<0.01).[6] 
Table 13: Cross-sectional surface areas of pores detected in and on the Optimaix 
3D Sponge1.  
 Outer Modified Centre Luminal 
Mean pore size [µm²] 590 6910 9650 2350 
Standard deviation 650 7210 7790 2180 
Median pore size [µm²] 340 4460 6440 1640 
 
Table 13 summarizes the results that are presented in Figure 40. The table and 
graphical illustration show that the pore sizes increased from the outer surface 
to the central matrix of the Optimaix 3D Sponge1. On average, diameters 
increased from 13.6 µm to 55.4 µm and reduced to 27.4 µm at the luminal site. 
Moreover, high standard deviations became apparent, caused by great variations 
in the cross-sectional area and diameter of the pores. The boxplot illustrates 
several statistical outliers that had an impact on the standard deviation. 
Nevertheless, differences between any two segments were significant (p<<0.01). 
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The Optimaix 3D Sponge1 showed interconnected, radially oriented pores, but 
these pores do not have a constant cross-section. From the results it has to be 
concluded that the outer and luminal pores were smaller, which may lead to a 
reduced cellular penetration depth. 
5.6.1.2 Application of cells to Optimaix 3D Sponge1 
Cell seeding onto the collagenous Optimaix 3D Sponge1 was performed either in 
a drop-on or dip-in procedure (see Chapter 4.6.1.1). Provided scaffolds had a 
length of about 8 cm, were dry and -sterilised. Test series with Optimaix 3D 
Sponge1 in combination with the Bioreactor Prototypes III and IV were done with 
shortened scaffolds (4 cm). Scaffolds with an initial length of 8 cm were cut into 
two halves with damp heat sterilised microtome blades, which were best suitable 
for slicing without damaging the material. 
In all cases, the bioreactor was sterilised with its components and tubes placed in 
an instruments tray with lid in an autoclave. Figure 41 shows both cell seeding 
procedures that were used to seed cells after to the fixation of the scaffold on two 
central fittings of the Bioreactor Prototype III and Prototype IV. Fixing the scaffold 
required high attention, because the dry collagen sponge tended to rupture in case 
of high shear stresses, caused by the cable ties. Therefore, the Optimaix 3D 
Sponge1 was carefully pushed over the fittings and cable ties were fixed. The 
cable ties were tightened slowly and carefully, while the scaffold was squeezed by 
hand at the position of the fitting. Compressed collagen sponges returned to their 
initial shape with a narrowing at the position of the cable ties, when they were 
wetted by cell culture medium or buffer solutions. 
Figure 41 A) shows the drop-on method where an adequate amount of cell 
suspension was added by pipetting. It can be seen that the scaffold was fixed on 
both central fittings inside the bioreactor. The applied cell suspension had a 
concentration of 5103-10103 cells µL-1, which was in the range of the 
manufacturer’s instructions (1103-40103 cells µL-1). 
For the dip-in procedure, the scaffold was immersed into a cell suspension with 
5103 cells µL-1 for 2-5 minutes. In Figure 41 B) shows that the scaffold material 
was attached to the bioreactor’s piston (see Figure 20) on one side and to a 
sealed piston on the other side. The immersed fitting was sealed with a silicone 
plug to ensure that an undesired cell type (muscle cells) did not get into the lumen 
of the prosthesis. 
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Figure 41: Seeding mechanisms for the Optimaix 3D Sponge1. The drop-on A) 
and dip-in B) procedure could be followed by a luminal seeding C). Homogenous 
cellular distribution was achieved by a rotatory unit D).[6] 
The luminal seeding of epithelial cells (Urotsa) is indicated in Figure 41 C). A cell 
suspension with 1103-5103 cells µL-1 was injected through the central fitting with 
a serological pipette. This was done slowly so that the cell suspension in the 
collagen matrix was not pressed out. Moreover, the tubes at the front plate and at 
the piston were closed after to the injection to keep the cell suspension in its 
position. 
Then, the bioreactor was placed and fixed in a rotatory unit (see Figure 41 D)). In 
this study, a rotation angle of 380° at a rotating speed of 0.05 rpm was applied. 
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The angle of more than 360° was chosen to ensure a homogenous distribution of 
the cells. A smaller rotation angle might lead to the fact that the cells cannot cover 
the tipping point. This setup and principle were similar to the “Slow Turing Lateral 
Vessel” described by Freed and Vunjak-Novakovic[170] as well as the reactor 
presented by Sodian et al.[60], where the bioreactors were turned around their 
longitudinal axis. In addition to that, literature shows that dynamic cultivations lead 
to improved reseedings of porous materials e.g. decellularised SIS or BSM, where 
the penetration depth was significantly increased.[83,84] Moreover, this cellular 
distribution has a direct influence on the development of the tissue replacement 
and cannot be neglected.[58] 
Experiments (n=3) were performed to investigate the period of time cells require to 
attach to a flat surface. It was demonstrated that this process took at least 6 hours. 
Primary cells were observed with the BioZero microscope to which an incubation 
chamber was attached. Nevertheless, long lasting rotations lead to an acidic 
environment for the cells. Cell metabolism leads to a pH drop in the cell culture 
medium and its environment. The ratio of cell culture medium referred to the cell 
count is significantly lower in these experiments compared to standard cultivations. 
This lead to a fast consumption of the medium. Therefore, a balance needed to be 
found between cell attachment, rotating speed and pH value.  
5.6.1.3 Co-cultivation on Optimaix 3D Sponge1 
A co-cultivation of at least two cell types was desired in the Bioreactor Prototypes 
III and IV. To that end, two independent medium circuits were established. Test 
series on co-cultivations were performed with C2C12 myoblasts that were seeded 
onto the outer scaffold and Urotsa, which were placed in the lumen of the 
prostheses. Independent experiments revealed that the seeding procedures were 
working well. It can be seen in Figure 42 that there were homogenous cell layers 
in the lumen and on the outer surface of the prostheses. A mixture of the cell types 
was not observed, because the outer surface still shows typical morphologic 
characteristics with spindle shaped cell bodies. Cells on the luminal surface show 
a cobblestone-like appearance, which is typical for epithelial tissues. 
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Figure 42: Co-cultivation of C2C12 myoblasts (spindle-shaped) and Urotsa (flat/cobblestone-like) on the outer surface A1)/A2), in the 
matrix B1)/B2) and lumen C1)/C2).[6] 
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These experiments (cf. Figure 42) showed that a basic application of two cell 
types on Optimaix 3D Sponge1 was possible. Nevertheless, it was noticed in 
the scanning electron microscopic pictures that no confluent seeding of the 
sponge matrix was possible. Cells were distributed in the matrix as depicted in the 
picture, but strong decreasing gradients (cf. Figure 38) were seen in any 
experiment that was performed.  
5.6.2 Fibrin and PVDF as matrix for a peristaltic stimulation 
As described in Chapter 3.2.4, composite biomaterials are better physiologic 
copies than single materials. This is based on the fact that tissues are made up of 
different layers that have different biomechanical properties, so composite 
materials offer a better chance to realise more of these properties and thus get 
closer to the original. 
5.6.2.1 The composite material used 
In this study, polyvinylidenfluoride and fibrin were combined as it had been done in 
previous studies by others (see Chapter 4.6.2). Figure 41 depicts the setup that 
was used in this study. It differed from other studies, e.g. from Tschoeke et al. 
(2011)[171], who covered the mesh with fibrin on both sides.  
The setup that can be seen in Figure 43 was chosen in order to ensure a 
stabilisation for the mechanical stimulation of the prostheses developed as ureteral 
interposition graft. This mechanical stabilisation supported the fibrin matrix and 
protected it against rupture during the stimulation. 
 
Figure 43: Schematic illustration of the two-component tubular structure 
consisting of fibrin (blue) as three-dimensional matrix and PVDF mesh (yellow with 
holes) as stabilising structure.[6] 
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5.6.2.2 Fibrin application – first test series 
Fibrinogen solution needed to be prepared prior to fibrin-matrix production 
according to the protocol that was presented in Chapter 4.6.2.1. Subsequent to the 
dissolution of the lyophilised fibrinogen, it was analysed by the  spectrophotometer 
at 280 nm. A dilution series were prepared (V/V) of 1:10, 1:20, 1:40 and 1:80 in 
Tris-buffer to achieve measureable concentrations with moderate absorptions up 
to 3. Two independent preparations were used in this study. Their measurement 
values are shown in Figure 44. The correlation coefficients (r2) of the lines of best-
fit were determined to be 0.999 and 0.997. 
 
 
Figure 44: Fibrinogen concentration in Tris-buffer measured at 280 nm in dilutions 
(V/V) of 1:10, 1:20, 1:40 and 1:80.[6] 
The measured results were used to calculate the protein concentration according 
to equation (2). Mean concentrations of 20.7 ± 0.6 mg mL-1 and 
20.5 ± 1.6 mg mL-1 were calculated. Aliquots were prepared and stored at -80 °C. 
First test series on fibrin preparation were done in combination with primary 
smooth muscle cells or NIH-3T3 fibroblasts that were poured in 24 well plates 
(Nunc) up to a level of 2.8 mm thickness. Figure 45 shows a fibrin matrix that was 
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prepared according to the protocol (see Chapter 4.6.2.1). The initial cell 
concentration was 100 cells µL–1.  
 
 
Figure 45: NIH-3T3 fibroblasts in fibrin gel with an initial concentration of 
12.5 mg mL-1 and 100 cells µL-1 after 7 days of incubation. Scale bar: 100 µm.[6] 
Subsequent to the cell seeding process it was observed that the cells started to 
grow into the fibrin matrix, where elongated/stretched cells were seen. After 7 days 
of incubation, it became apparent that there was a homogenous distribution of the 
cells in all spatial directions inside the matrix, which was proven with z-stack-
recordings. Moreover, NIH-3T3 fibroblasts showed the typical morphology, having 
developed several pseudopodia for cellular communication.[172] The low initial cell 
count was chosen to allow monitoring with light microscopy. Too high 
concentrations would have lead to optical opaque constructs.  
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5.6.2.3 Casting of fibrin into a tubular structure 
A casting mould was developed for the application of fibrin, cells and a PVDF 
mesh. First evaluations of the plastic material’s performance in combination with 
fibrin were achieved by applying of a fibrinogen-thrombin solution onto polished 
plastic surfaces. Effects became directly visible as it is shown in Figure 46, where 
fibrin was applied on polished PTFE A) and polished POM B). The fact that drops 
on the PTFE showed much steeper contact angles than on POM was clearly 
visible by the naked eye; therefore no contact angle measurements were 
performed. After an hour, it was noticed that it was possible to remove the 
polymerised fibrin more easily from PTFE. It was concluded that PTFE is much 
more hydrophobic and that there was less adhesion. This is based on lower 
surface tensions leading to fewer interactions between the material and the 
liquid.[173] 
 
 
Figure 46: Fibrin applied on A) PTFE and B) POM to select a suitable material for 
a casting mould.[6] 
A) 
B) 
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The fibrin casting mould developed for this thesis was prepared out of PTFE. It 
was manufactured in the workshop of the Aachen, University of Applied Sciences 
in Jülich according to the technical drawing shown in the Appendix. A schematic 
illustration is given in Figure 47. The mould, (except bolts, nuts, fittings, pins and 
the LUER adapters) consisted of PTFE. Its fittings were manufactured from POM 
and bolts, nuts, pins and LUER connectors consisted of stainless steel. 
 
 
 
Figure 47: Fibrin casting mould consisting of: top (1), bottom (2), pins for 
positioning (3), fittings (4), central rod (5), front cap (6), end cap (7), wing 
bolts/nuts (8)/(9) and LUER adapters (10).[6] 
The casting mould was assembled completely, prior to the application of the fibrin, 
cells and PVDF mesh. A fitting (4) (cf. Figure 21) was screwed down into the end 
cap (7), which has been already attached to the central rod (5). A prepared piece 
of mesh was pulled over the rod and fitting, before the second fitting was added. 
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This combination was then set onto the bottom plate (2). The top (1) was adjusted 
in a way that the LUER adapters (10) (VIEWEG) arranged in an antiparallel 
manner. Stainless steel pins (3) (MISUMI) supported a correct adjustment. 
Subsequently, the wing bolts and nuts (8)/(9) were attached to close the casting 
mould tightly, before the front cap was screwed down. In this case, additional bars 
at the short sides of the casting mould fixed the fittings that had a wrench size of 
12 mm. Thus, no twisting of the scaffold was avoided, which could have lead to 
inhomogenities, e.g. wrinkles. 
Afterwards, cells were applied to the assembled casting mould. To achieve that, 
cells were detached from cell culture flasks with Trypsin/EDTA (see 
Chapter 4.4.3). Then, they were resuspended with cell culture medium II and were 
counted with the cell counter (see Chapter 4.4.4). For one experiment with two 
prostheses, a total cell count of 6107 cells was required. This lead to a final cell 
concentration of 5106 cells mL-1. The cells were centrifuged at 280 g again to be 
resuspended in TBS-buffer to a total amount of 2.1 mL. The two-chambered 
applicator was used with 3 mL fibrinogen solution (12.5 mg mL-1), which was 
separated from the 2.1 mL cell suspension, 450 µL thrombin (40 U mL-1) and 
450 µL CaCl2 (50 mM) (see Chapter 4.6.2.1). The suspension needed to be 
injected with consistent speed to achieve a prosthesis with a homogenous shape, 
as shown in Figure 48. Moreover, the casting mould was arranged vertically to 
avoid bubbles/holes in the tubular construct. Thus, the filling level kept constantly 
moving upwards. 
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Figure 48: Homogeneously casted fibrin prosthesis with a length of 75 mm in the 
developed casting mould.[6] 
The fibrin was allowed to polymerise for 45 minutes before the casting mould was 
opened. To open the mould, the front and end cap were removed and the piston 
and front plate of the Bioreactor Prototype IV were attached. The piston had been 
already introduced in the glass cylinder. Subsequently, a stainless steel rod 
(320 cm) was driven through the central fittings to ensure a support of the 
prosthesis. Then, the topper and bottom were removed carefully and cable ties 
were applied to fix the prosthesis on the fittings.  
When fitting configuration B) (cf. Figure 21) was used, boreholes were cleared by 
cutting holes into the mesh in the direction of the piston or front plate. These 
fittings were required for the central cell culture medium support. Then, the piston 
was pulled through the glass cylinder till the front plate closed the bioreactor. The 
metal housing was attached to achieve tight sealing before the central metal rod 
was removed and before the tubes from the reservoirs were attached to the 
bioreactor. For stimulated prostheses, the contamination guard was connected to 
the bioreactor’s piston to introduce the kyphoplasty catheter that had been cleaned 
with an antiseptic agent and sterilised at 90 °C for at least 12 h. Additionally, the 
front plate was sealed with a silicon plug. 
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Untrained/unstimulated prostheses were placed in the incubation system and the 
tubes for the medium supply were put into the peristaltic pump heads. Cell culture 
medium III (see Chapter 4.4.2) was transferred with 10 rpm (8.6 mL min-1). 
Trained/mechanically stimulated samples were placed in the bioreactor system 
and only the outer medium circuit was attached. The pressure line had been filled 
with degased water before it was connected to the catheter.  
For the preparation of the fibrin prostheses it was shown that homogeneous 
tubular structures were prepared with a wall thickness of 2 mm. The casting 
mould was tightly sealed and had a total volume of nearly 6 mL, leading to a 
total scaffold length of 75 mm. The length between the fittings was 55 mm. Fibrin 
did not attach to the PTFE resulting in an easy removability of the prostheses. 
Potential for improvements can be seen with respect to the location of the fittings. 
The wall thickness was just 1 mm at the position of the fittings. At this position, 
however, the prostheses were most fragile. 
5.6.2.4 Observations during the incubation period 
Incubation procedures with fibrin-based prostheses were conducted for 1 (n=4) 
and 2 (n=4) weeks. Every day during this period of time, cell culture medium 
samples of 3 mL were taken and the outer appearance of the prostheses was 
examined. 
The first test series revealed that the Cyklokarpron® concentration in cell culture 
medium III needed to be increased from 0.16 mg mL-1 to 0.5 mg mL-1 to slow down 
fibrin degradation (see Chapter 4.6.2). Its concentration was adapted to levels 
found in literature where Cyklokarpron® was used in combination with other cell 
types.[174] This was necessary because the urothelium produces tissue-type 
plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) that 
lead to the degradation of fibrin (see Chapter 4.6.2). It may be assumed that, this 
secretion prevents fibrin clots from obstructing the urine guiding system.[175] In this 
study, SMCs were isolated from porcine bladders which lead to cellular cross 
contaminations in any case. 
In the future, this prosthesis will need to be seeded on the luminal surface to 
improve tissue tightness (see Chapter 2.1.1). To achieve that, an additional 
seeding step is required. In this case, an additional layer of fibrin might be 
attached to the luminal PVDF, so that there is a more homogenous and smooth 
surface. The procedure may be adopted in accordance with Tschoeke B. et al. 
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(2008)[171]. A casting mould with a central cylinder (di <6 mm) could be used to add 
the inner layer of fibrin. Subsequently, the luminal seeding with urothelial cells may 
be performed. 
Moreover, the connection between PVDF mesh, fibrin and cells could be improved 
further with covalent bonding of extracellular matrix (ECM) proteins, e.g. 
fibronectin[136], or different ECM cell adhesion domain frequencies (RGDs)[176].  
During the incubation and stimulation, no prostheses were lost because of failure 
at the PVDF mesh. However, the PVDF meshes used in this study were knitted, 
which had the advantage of providing very high variability regarding mechanical 
and structural characteristics.[140] Different knitting patterns have a direct influence 
on the cellular behaviour. Thus, additional experiments should be performed 
comparing altered weaving patterns to unwoven patterns.[177]  
5.6.3 Porous sponge vs. compact extracellular matrix 
Significant differences between the scaffold materials became apparent when the 
bioreactor was opened directly after the incubation. When the bioreactor was 
emptied, a thin biofilm became visible on the inside of the glass cylinder only in 
cases where Optimaix 3D Sponge1 had been used. This film was not seen in 
experiments with fibrin-based scaffolds. Light microscopy identified the cell type 
that was seeded onto the Optimaix 3D sponge1. Figure 49 shows two glass 
cylinders subsequent to the incubation with Optimaix 3D Sponge 1 A) and fibrin-
based scaffolds B). 
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Figure 49: Comparison of the situation in Bioreactor Prototype IV after the 
incubation with Optimaix 3D Sponge1 and fibrin.[6] 
These photographs illustrate that cells that were seeded onto the sponge like 
matrix dropped out of the pore system. Obviously, not all cells were tightly 
attached to the collagen sponge. That lead to a loss of cells after the bioreactor 
had been flushed with cell culture medium and to cells attaching to the inner 
surface of the glass cylinder. Cells proliferating inside the bioreactor but not in/on 
the scaffold resulted in an unnecessary consumption of cell culture medium. 
Moreover, this may contribute to failures in cell culture medium analysis with 
respect to any parameters that might be used for quantitative or qualitative 
examinations. This effect was not observed for fibrin-based prostheses (Figure 
49 B)), where cells were casted into their position inside the matrix. Subsequent to 
the casting, the cells grew into the matrix by reorganising it. However, no cells 
were flushed out of this scaffold. 
Figure 50 shows a control scaffold. It did not contain cells but was treated in the 
same way as an unstimulated prosthesis. In this picture, the fine fibrin meshwork 
becomes apparent and leads to the conclusion that entrapped cells cannot be 
flushed out of the matrix, even if they have not yet attached to the fibrin mesh. 
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Figure 50: Control scaffold prepared out of fibrinogen without cells incubated with 
medium III in the Bioreactor Prototype IV for 1 week. Protein agglomerations as 
well as fibrin filaments can be identified.[6] 
As a conclusion it can be stated, that tissue engineering with Optimaix 3D 
Sponge1 has not been yet successful, even though results of in vivo and 
classical in vitro experiments were suitable and encouraging for further 
investigations. It was demonstrated that the seeding of cells did not lead to a 
homogeneous cellular distribution and confluency inside the matrix. Strong 
gradients were seen from surface layers into the matrix. Problems may be traced 
back to the dimensions and pore sizes of the matrix and/or the combination of 
material and bioreactor system. The conclusion is that this matrix in combination 
with Prototypes III and IV, and the structural setup of the sponge-like material 
were not applicable for tissue engineering purposes. 
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5.7 Ussing chamber 
The Ussing chamber was used to examine the tissue’s tightness against the 
diffusion of urinary excreted substances (see Chapter 4.4.1.4). Urea and 
creatinine were analysed in the veterinary laboratory of the RWTH Aachen 
University Hospital. Generally, these molecules are common renal markers that 
can be found and quantified in the urine.[178] 
Urea (CH4N2O; 60.06 g mol
-1) is a degradation product of amino acids and can be 
used to determine the integrity of the urothelium.[13,14,179] 
Creatinine (C4H7N3O; 113.12 g mol
-1) is nearly twice as heavy as urea. It is a 
metabolic waste compound from creatine to creatinine in muscles.[178] 
First, native porcine ureters (n=7) were prepared to be analysed in the Ussing 
chamber. The preparation of porcine ureters for the application in the Ussing 
chamber can be seen in Figure 51. 
 
 
Figure 51: Preparation of native porcine ureters to prior to analysis of passive 
diffusion of urine-excreted substances. Connective tissue at the native bladder and 
ureter (black) A) was removed with scissors to obtain a pure ureter (red) B). 
Clamps at the top mark the urachus.[6] 
Marks in this figure, indicate that excessive fatty connective tissue was removed 
from the native bladder and ureter A) in order to get a ureter samples without 
disturbing tissue B). Any tissue up to the adventitia was dissected with sharp 
A) B) 
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scissors and fine tweezers. It was ensured that the adventitia was still intact after 
the preparation, because any damage may have a direct influence on the diffusion 
experiments. 
Ureters were cut into fragments with a length of about 2 cm and were opened in 
longitudinal direction. Subsequently, the samples were fixed on the specimen 
mounts before the chambers were closed and the reservoirs were filled with 5 mL 
of the specific buffer solutions each (see Chapter 4.4.1.4). 
The same procedure was performed with tissue-engineered fibrin-based 
prostheses. After the bioreactor has been opened, prostheses were cut into 
fragments with a length between 0.5 cm and 1 cm. Then, a sample was randomly 
chosen before it was sliced longitudinally. 
In every case, the luminal/urothelial layer was directed towards the synthetic urine, 
i.e. in the physiologic diffusion direction. 
Figure 52 shows measurement curves for native and tissue-engineered structures 
with respect to the diffusion of urea. Mean values were calculated for native 
samples (green) as well as for trained (blue) and untrained (red) prostheses. 
Additionally, the overall statistical mean (black) of tissue-engineered structures 
was introduced for comparison. 
It can be seen that urea was much better able to penetrate tissue-engineered 
constructs than native ureteral tissues. The difference was significant. After 
8 hours, there was a mean difference of 140 mmol L-1 between native and tissue-
engineered samples. This was based on the fact that tissue-engineered constructs 
did not have a luminal urothelium, which is one of the tightest tissues in the human 
body (see Chapter 3.1.1). Besides that, histological staining revealed that cellular 
densities are lower in tissue-engineered matrices, which may have contributed to 
the increased diffusion rates. 
Moreover, a difference can be seen between trained and untrained prostheses, 
which are separated from each other in the picture by the overall mean value of all 
fibrin-based prostheses. That means trained prostheses seem to be slightly more 
leaky than untrained constructs. Nevertheless, this effect is not significant. 
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Figure 52: Diffusion of urea through tissue-engineered, trained and untrained 
prostheses (n=14) and mean tissue-engineered constructs in comparison to native 
ureters. TE=tissue-engineered.[6] 
Creatinine diffusion is illustrated in Figure 53. It becomes apparent that the 
diffusion characteristic was comparable to the diffusion of urea. Colour coding of 
the samples is the same as in Figure 53. The permeation of creatinine was 
significantly higher for tissue-engineered constructs after 8 h; the difference 
amounted to 1940 µmol L-1. Moreover, the statistic mean of trained prostheses 
(blue, n=7) lies above the overall mean (black, n=14). Untrained prostheses (red, 
n=7) were slightly denser than the overall mean.  
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Figure 53: Diffusion of creatinine through native ureters (n=7), trained and 
untrained prostheses (n=14) and mean tissue-engineered constructs. TE=tissue-
engineered.[6] 
Both experiments reveal that untrained prostheses are not significantly denser with 
respect to diffusion than trained prosthesis. The low number of experiments with 
n≤8 may explain a merging of the curves. In case of single evaluations, where one 
trained and one untrained prosthesis comprising primary cells from one donor 
were compared it was observed that the trained prostheses showed higher 
leakage of urea in 5 of 8 experiments. With respect to creatinine, 6 of 8 
experiments showed higher leakage in trained prostheses. 
Once, an evident failure was observed during the experiments, when air bubbles 
got stuck at the tissue. This reduced the surface area available for diffusion and 
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the results were affected negatively. For that reason, this experiment was 
excluded from the analysis. 
Another influencing factor m be seen in different donors. No data were available 
on the age of the pigs that were used. No differentiation was made between the 
pigs’ genders. Moreover, differences between races might matter. 
It was suggested that creatinine diffuses more slowly than urea. This was based 
on the assumption that the molecular size of creatinine is bigger than that of urea 
and that its concentration gradient is lower from synthetic urine to Krebs buffer. 
The diagrams showed that the average diffusion per hour was 290 µmol L-1 h-1 for 
creatinine and 22 mmol L-1 h-1 for urea. Consequently, the relative diffusion is 
higher for urea, which may be a result of its molecular size and concentration 
gradient. 
In fact, no significant difference of tissue-engineered constructs was 
observable with respect to the diffusion of urea or creatinine. Differences 
between trained and untrained prostheses were too little to be significant. 
Additionally, an incubation period of two weeks could not increase tissue 
impermeability in comparison to one week incubation periods. 
Literature gives little information on the diffusion of urea both in the genitourinary 
tract and in tissue-engineering constructs. Only a few scientists are working with 
diffusion chambers. Nevertheless, a comparison is difficult because media as well 
as experimental setups were different.[180,181]  
However, Cattan V. et al. (2011)[180] showed the influence of the urothelium at 
tissue-engineered constructs for the genitourinary tract regarding the tightness 
against diffusion of urea. It was shown that the urothelium stratified due to 
mechanical stress, which has a significant influence on urea permeation. 
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5.8 Bursting pressure 
In order to compare mechanical properties of tissue-engineered prostheses, the burst 
pressure of fibrin-based constructs was examined. For that reason, an experimental 
setup was designed that is schematised in Figure 54. 
It can be seen that a tube connected a syringe with a cube-shaped pressure 
chamber, which was developed for this purpose. It was manufactured in the 
workshop of the Aachen, University of Applied Sciences, Jülich, according to the 
technical drawings contained in the Appendix. The massive cube was equipped with 
a central borehole (di= 4 mm). To clamp the specimen, it was possible to attach a 
plate with a thickness of 1 cm to the cube. The plate was fixed with four screws. To 
enable proper sealing and clamping, a seat for an O-Ring (1.58 mm) was milled into 
the cube. Basically, this pressure chamber replaced the kyphoplasty catheter that 
was used for peristaltic stimulation of fibrin-based constructs (see Chapter 5.2.1). 
The SyrDos syringe pump was used to apply a constantly increasing pressure onto 
the specimens by adding a volume of 2 µL s-1. Pressure was monitored by the 
pressure sensor that was attached parallel to the pressure line. Hence, a qualitative 
comparison of the results became possible.  
The measurement was done after Bioreactor Prototype IV had been opened and 
fibrin-based prostheses had been sliced into pieces between 0.5 cm and 1 cm length. 
Tubular structures were cut twice in longitudinal direction to obtain two tissue 
fragments of the same size. Furthermore, the chamber was flushed so that there was 
no air left in the system. Samples were chosen randomly for analysing their rupture 
pressure. The outer surface of a specimen was directed to the pressure line in the 
direction of the junction. Thus, pressure was acting on the fibrin which was then 
pressed against the PVDF mesh. Four screws fixed the covering plate. 
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Figure 54: Bursting pressure test setup with a syringe pump and a specially 
designed chamber to attach a pressure line. The fibrin layer (red) is directed to the 
top and the underlying PVDF mesh (grey) is in contact with the atmosphere.[6] 
This measurement was directly started in HiText™. The syringe pump was filled with 
water and released it continuously with 100 steps s-1. Pressure values were recorded 
with 10 Hz. Generally, the amount of analysed fragments of a prosthesis varied 
between two and five. A typical burst pressure curve is illustrated in Figure 55. This 
figure shows that the pressure was constantly increasing from atmospheric pressure 
to a maximum, where the tissue ruptured. Then, the pressure decreased to 
atmospheric pressure again.  
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Figure 55: Typical progress of a burst pressure experiment using the example of an 
unseeded fibrin-based control sample.[6] 
The rupture pressure for a fibrin-based control sample was determined to be 
1280 ± 130 mbar. Pure PVDF meshes were not able to retain the liquid in any way, 
resulting in maximum pressures <20 mbar, which may be a result of the capillary 
resistance. 
Figure 56 illustrates the overall results that were achieved regarding fibrin-based 
prostheses that were seeded with primary porcine smooth muscle cells and 
incubated for 1 week or 2 weeks with and without peristaltic stimulation. Red 
coloured boxplots untrained prostheses and blue boxes indicate trained prostheses. 
Both colours allow a further differentiation between the donor pigs. Primary smooth 
muscle cells from one donor were used for each experiment (i.e. 8 donors were 
used) and marked with an alphabetic character. One prosthesis was prepared for 
mechanical stimulation (blue) and one without training (red). Experiments lasting 1 
week range from A1 to D2, whereas prostheses from E1 to H2 were incubated for 2 
weeks. 
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Figure 56: Bursting pressures of tissue-engineered tubular structures based on 
fibrin-PVDF prostheses incubated for 1 week (A-D) and 2 weeks (E-H).[6] 
Figure 56 shows two spikes for C1 and C2. These samples show a significantly 
increased mechanical stability in comparison to all other prostheses. Their mean 
values were at least twice as high as the others. For that reason, these two samples 
(C1 and C2) were excluded from further analysis. Moreover, no measurement was 
possible for F2 due to fibrinolysis. This might be caused by a high contamination with 
urothelial cells that were found as cell clusters after HE histological staining.  
Corrected charts are shown in Figure 57 with the samples C1/C2 and F1/F2 
removed. These diagrams differentiate between one week and two weeks of 
incubation as well as trained (blue) and untrained (red) prostheses. 
An analysis of the median bursting pressure in intraindividual experiments using from 
one donor shows that the median bursting pressure of trained prostheses was 
greater than the rupture pressure of untrained prostheses in 4 of 6 experiments. The 
differences between A1/A2, B1/B2 and H1/H2 cannot be proven to be significant 
because of the low number of measurement values in one experiment (n≤5). 
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Figure 57: Bursting pressures of fibrin-based prostheses differentiated according to 
their incubation periods.[6] 
 
Additionally, Table 14 shows the mean values of the medians of trained and 
untrained prostheses for 1 and 2 weeks of. It becomes apparent that trained 
prostheses show a higher rupture pressure and a standard deviation that is at 
least half of the standard deviation of untrained prostheses. This may show a 
greater homogeneity in trained constructs with respect to cellular distribution, 
extracellular matrix secretion and strengthening or orientation. 
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Table 14: Mean of the median bursting pressures according to experiments shown 
in Figure 57. 
Incubation period 
Median bursting pressure 
untrained [mbar] 
Median bursting pressure 
trained [mbar] 
1 week 1210 ± 310 1530 ± 50 
2 weeks 1450 ± 530 2120 ± 200 
 
Figure 58 summarises the measurements that are shown in Figure 57. The same 
trend becomes apparent that was shown in Table 14. The boxes, or the 
interquartile range, of trained prostheses (blue) are smaller than to those of the 
untrained constructs (red). Thus, 50% of the measurement values were distributed 
in a smaller range. 
Nevertheless, it can be seen that the whiskers that are based on the one and a 
half times the interquartile range were greater for experiments with an incubation 
period of two weeks. Statistical outliers, that would be indicated by circles, were 
not observed. 
All in all, a positive trend may be seen in Figure 58 for increasing bursting 
pressures over time for trained and untrained prostheses. This tendency is 
not yet significant and needs to be proven by further experiments. 
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Figure 58: Boxplot of bursting pressures of samples shown in Figure 57. 
Differentiation is made with respect to the incubation periods: 1 week 
(untrained1/trained1) and 2 weeks (untrained2/trained2).[6] 
The amount of analysed samples per prosthesis varied because of the loss of 
specimens. Insufficient fixation/clamping due to slipping out of the position where 
the central borehole was covered completely, lead to the loss of tissue fragments. 
This could be reduced during the experimental phase so that just one experiment 
(A1/A2) contained n=2 measurement values per prostheses. For that reason, a 
specimen mount with pin points is suggested as a further optimisation. 
All in all, the achieved results correspond to literature that deals with tubular tissue 
engineering at the urinary tract and that considers mechanical stability of grown 
prostheses. It can be stated that the rupture pressure or the mechanical stability of 
prostheses increases with time and dynamic incubation.[182] Similar effects can be 
observed for vascular tissue engineering.[112] A comparison to these studies is 
difficult, however, due to different approaches with different cell types, geometries 
and biomaterials. 
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5.9 Evaluation of cellular orientation 
The orientation of smooth muscle cells both along the ureter and circularly around 
the ureter are key features required for peristaltic forwarding of urine from the 
kidneys toward the urinary bladder (see Chapter 3.1.1). For that reason, cellular 
orientation in and on the tissue-engineered fibrin-based tubular structures were 
analysed.  
5.9.1 Outer surface and scanning electron microscopy 
Generally, the outer surface of the tubular structures was analysed by means of 
scanning electron microscopic pictures.  
The outer surface of the tissue-engineered tubular structure made up of fibrin and 
primary smooth muscle cells was evaluated with the help of a computer program 
written in LabVIEW. An individualised graphical user interface (GUI) was designed 
in the lab with the support of Peter Linder, M.Sc., in order to find the alignment of 
pictorial elements in the raster electron microscopic pictures. Figure 59 shows the 
GUI with the different steps of the image processing. A) indicates the selection of a 
survey image. The major part of the sample and its cutting edges are visible for 
the identification of the sample position. All orientations of particles and cells are 
referred to a reference line that was placed in this survey (Figure 59 B). In C), a 
second image with an effective magnification factor of 400 was loaded and a 
Gaussian filter applied to smoothen this image to remove speckles. In this display, 
it was possible to define a region of interest (ROI), where disturbing elements, e.g. 
the image annotation, were excluded. Subsequently, two further images (Figure 59 
D) and E) were prepared. Image D) was strongly smoothed with a low pass filter 
that had a grid of 2020 pixels and a tolerance of 10%. The second photo, E), was 
smoothed weakly with a grid of 1010 pixels and a tolerance of 5%. Subsequently, 
the figures were subtracted from each other and the absolute subtraction image 
was analysed with the LabVIEW particle detection tool using the parameters 
indicated in Figure 59 F). Data containing the orientation of identified particles and 
structures G) were put into the histogram H) and exported into an Excel sheet. In 
this example, the mean orientation of structural elements was 140° compared with 
the reference line. That means that these elements were shifted by 50° with regard 
to the longitudinal axis of the tubular structure. Moreover, this example showed an 
interquartile range of 30°, which indicates that 50% of all investigated orientations 
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were in the range the median orientation. The narrower this interquartile the more 
aligned the structural elements and cells. Widely distributed structures show 
interquartile ranges of around 90°. An interquartile range of 180° indicates an 
orientation along the reference line. In all images, the reference line equalled a 
circular arrangement of objects. Thus, a mean value of 90° indicates a longitudinal 
arrangement of the cells on the outer surface. 
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Figure 59: LabVIEW GUI for the evaluation of the structural alignment on the outer surface of the tissue-engineered prosthesis. 
Labels indicate different steps for image processing with filters and standardised analysing tools.[6] 
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Figure 60 and Figure 61 show test patterns for strongly aligned elements and a 
homogenous distribution. In the first example, the analysing software revealed an 
interquartile range of 0°, which indicates that there was no variation in the 
orientation of the test elements. In contrast to that, Figure 61 shows a 
homogeneous distribution of the elements. 50% of all particles were in the range 
of 90° around the virtual “centre” orientation. Hence, 50% had to be distributed in 
the remaining 90°. This shows a homogenous distribution over all possible 
orientations in the range of 180°. Consequently, there was no preferred alignment 
of objects was detected. 
Both situations are displayed in the histogram. Strong orientations lead to a high 
and narrow peak, while broad distributions indicate arrangements spread over a 
wide range. 
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Figure 60: Test pattern for the illustration of strongly aligned elements. The analysis reveals an interquartile range of 0, a mean 
orientation of 90° and a standard deviation of 0.[6] 
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Figure 61: Test pattern for the illustration of strongly aligned elements. The analysis reveals an interquartile range of 91, a mean 
orientation of 92° and a standard deviation of 54.[6] 
Results and Discussion 
 122 
Difficulties with this evaluation occurred with pictures that had a low contrast and 
where probably a urothelial cell contamination was prominent. In this case, 
pictures looked similar to Figure 42 C1), where Urotsa was applied on Optimaix 
3D Sponge1. Moreover, it was observed that high numbers of round particles, e.g. 
protein fragments, impair the evaluation as well as the view onto the sample. 
Possible consequences are optical distortion and preferential orientations. 
Figure 62 shows the resulting orientations of fibrin-based prostheses in a boxplot. 
It can be seen that generally all possible directions (0°-180°) were seen on the 
outer surface of trained and untrained prostheses; this is indicated by the whiskers 
(dotted lines; one and a half times the interquartile range) and outliers (circles). 
Nevertheless, just trained prostheses (blue) presented to outliers, resulting in a 
narrower distribution of measured angles around a mean value. 
All in all, untrained prostheses show bigger boxes (red) covering a range from 69° 
to 134°. In contrast to that, the interquartile ranges of the blue boxes (trained 
constructs) lay between 24° and 44°.  
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Figure 62: Evaluation of the alignment of all structural elements in a scanning 
electron microscopic picture of the outer surface of fibrin-based prostheses. 
Trained prostheses are coloured in blue, untrained in red.[6] 
The interquartile ranges seen in Figure 62 were summarised for each group 
(trained and untrained prostheses). The means of the interquartile ranges with 
their standard deviations are shown in a bar plot in Figure 63. The mean 
interquartile range for untrained prostheses was 95 ± 12°, compared to 
34 ± 6° that were determined for trained prostheses. The null hypothesis of the 
Wilcox rank-sum test, where both groups are the same, was rejected with 
p=0.002. 
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Figure 63: Size of the interquartile ranges showing the orientation of structural 
elements on the outer surface of untrained (red) and trained (blue) prostheses. 
The difference between the groups is significant (p<0.05) according to the results 
of the Wilcoxon rank-sum test.[6] 
From these experiments and based on this examination it can be concluded that 
there was a preferred orientation of structural elements that became visible in 
scanning electron microscopic pictures of trained prostheses. A mean interquartile 
range of 95° for untrained prostheses leads to the conclusion that there is no 
prominent arrangement of elements in this group. In contrast to that, it can be 
seen that the mean angular distribution of trained prostheses was 34°. Moreover, 
trained prosthesis show a mean orientation of structural elements and cells 
of 93° in a longitudinal direction. 
* 
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5.9.2 Cross-section and classical histology 
Evaluations on cellular orientation in cross-sectional pictures were performed with 
microscopic pictures, taken with a light microscope, after the cells had been 
stained with haematoxylin & eosin (HE staining). A computer based GUI 
(cf. Figure 65) was prepared in LabVIEW with the support of Peter Linder, M.Sc. It 
was similar to the program that was described in Chapter 5.9.1. Significant 
differences to the previous program can be seen in the structure that is analysed 
in the corresponding pictures. Scanning electron microscopic pictures were 
analysed with respect to the orientation of particles. The main focus was put on 
the orientation of cellular borders that create high contrast regions in the picture. 
Therefore, cellular orientation was determined indirectly. In contrast to that, 
histological pictures analysed cellular orientation directly. This is based on the fact 
that single cells could be identified more easily than in scanning electron 
microscopy pictures, where the identification of single cells was challenging. 
Figure 64 shows an example of an HE stained cross section of a trained fibrin 
prosthesis with a higher magnification than used for analysis. This was done in 
order to make the elements stand out to make further evaluation easier. In this 
figure, elongated cell bodies become apparent that were used for analysis. Such 
histological cross sections allow an automatised identification of cells, which was 
not possible with scanning electron microscopic pictures.  
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Figure 64: Cross section of a tissue-engineered and trained sample stained with 
haematoxylin & eosin. Scale bar: 50 µm.[6] 
Pictures selected for analysis were loaded into the program and the fragments of 
the tubular samples were horizontally adjusted to the angle entered manually (see 
Figure 65 A). The pictures were then horizontally adjusted and displayed on the 
GUI, where a region of interest (ROI) was defined for the prostheses B). After that, 
the red image plane was subtracted C). Speckles were extracted according to a 
filter that was included in LabVIEW (Nth-order), where the nth value (30) of a 
defined region (1010 pixels) was used to smooth the picture. After that, the 
particle (here: cell) detection was carried out according to the settings (F). The 
detected particles were displayed in E) and analysed according to their orientation 
F). To achieve that, their longitudinal axes were evaluated with respect to the 
horizontal orientation of the sample (cf. Figure 65 A)). 
It was possible to demonstrated that inhomogeneity of the sample’s density and 
thus in the coloration of the histological pictures lead to problems in the analysis of 
the cellular orientation. In these cases, holes or loose tissue segments were 
identified as cells and included in the statistics, even if they were artefacts. This 
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effect was reduced by defining the ROI as well as by setting a minimum object 
size of 300 pixels. Moreover, embedded cell clusters (urothelial cells) impair the 
analysis due to their round morphological appearance.  
For further improvement, an additional weighting of the cellular orientation could 
be performed with respect to the aspect ratio of the cellular shape. This means 
that elongated, spindle shaped cells would have a stronger impact in statistics 
compared to rounder cells. 
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Figure 65: Graphical user interface for the analysis of histological pictures to evaluate cellular orientations. Labels indicate the 
evaluation process beginning with the loading and horizontal alignment of the picture/sample (A). A ROI was defined (B), before the 
red image plane was subtracted (C). Speckles were filtered (D) and a local threshold for the pixels’ colour was set, before the 
particles/cells were identified (E) according to the settings (F). Results were evaluated (F) and were indicated in a histogram (G).[6]
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Figure 66 shows the angular distribution of cells in a fibrin matrix referred to a 
horizontally arranged sample. Thus, an angle of 0° was equal to a circular 
arrangement of the cells. It can be seen that cells were distributed in all possible 
directions from 90° to -90°. All medians were in the range of 26°. Moreover, they 
were distributed around 0°, showing that there were preferred orientations in a 
circular direction. 
 
 
Figure 66: Cellular alignments in untrained (red) and trained (blue) fibrin 
matrices.[6] 
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Figure 67 analyses the size of the interquartile ranges of the angular distribution of 
cells inside the fibrin matrices. It can be seen that the mean of the interquartile 
ranges of untrained prostheses (red) was 45 ± 10° and 15 ± 3° for trained (blue). 
Both groups differ significantly indicating a narrower distribution of cellular 
orientation with mechanically stressed prostheses. 
 
 
Figure 67: Size of the interquartile ranges showing the orientation of cells in a 
fibrin matrix of untrained (red) and trained (blue) prostheses. The difference 
between the groups is significant (p<0.05) according to the results of the Wilcoxon 
rank-sum test.[6] 
The analysis of the cellular orientation inside the fibrin matrix reveals that even 
untrained cells showed a preferred direction. This might be based on the fact that 
peristaltic pumps ensured the cell culture medium supply. Even slow turning 
(10 rpm) pump heads could caused a pulsatile flow which might have contributed 
to a preferred orientation of the cells. Nevertheless, this stimulation was not as 
effective as for trained prostheses (cf. Figure 67). 
* 
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During the work on this thesis, no other literature was found that deals with the 
alignment of primary, porcine bladder smooth muscle cells in a tubular 3D matrix. 
In this study, special focus was placed on the orientation of cells in different layers. 
All in all, it was concluded from the analyses carried out after a peristaltic 
stimulation with a catheter, that there was a certain preferred growth direction on 
the outer surface of tubular fibrin-based prostheses. The orientation inside the 
matrix was found as it had been expected for stimulated constructs. This 
alignment of cells was often found in literature for mechanically stressed 
structures, especially for vascular tissue engineering.[74,183]  
It became apparent, that cells reacted to the applied mechanical stimulation 
with bidirectional growth. Angles were shifted by 90°. Nevertheless, the 
achieved structural setup was reversed, with a stratum circulare followed by a 
stratum longitudinale that was observed on the outer surface. Moreover, it could 
be seen that this layer had a thickness of only few (<5) cell layers. 
For further experiments, numerous variables could be diversified, e.g. the 
stimulation frequency, intensity, incubation period, cell count or even the matrix 
composition. 
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6 Summary 
This study is placed in the field of tissue engineering, which comprises several 
technical and medical engineering disciplines dealing with the generation of 
tubular constructs as replacements damaged parts of the genitourinary tract. 
Numerous primary and iatrogenic diseases affect the ureters, leading to severe 
injuries. A reliable bridging of ureters is not yet trivial. Even though bridging with 
small intestine is the gold standard, it still involves negative side effects, e.g. 
mucous production. Generally, it can be seen that tissue engineering is performed 
in various medical fields. Nevertheless, genitourinary tissue engineering and 
especially tubular tissue formation is not in focus. This is probably due to the fact 
that tissue-engineered constructs have to withstand a very complex natural milieu. 
The few publications on tubular tissue engineering of the urinary tract are based 
on experiments in bioreactors, where no physiologic mechanical stimulation is 
applied. Most bioreactors that were utilised, create pulsatile flows for stimulation. 
Obviously, a lot of attention is paid to the urothelium that plays a crucial role in 
tissue tightness in the urinary tract. Reducing its role merely to its barrier function, 
however, would underrate the importance of the urothelium. Further, it excretes 
signalling molecules and to protects against infection. Additionally, the studies 
mentioned neglect the function of the smooth muscle cell layer and the fact that an 
application of muscle cells inside the matrix is necessary to reduce shrinkage. 
Shrinkage and fibroblast incorporation are seen as major hindrances leading to 
postoperative complications. The presented study is intended to contribute to the 
bridging of the gap. 
The bioreactor system used was developed in the labs for Cell Biophysics and 
Medical & Molecular Biology of the Aachen, University of Applied Sciences, Jülich. 
It was developed to enable temperature and carbon dioxide regulation during 
cultivation periods of at least 2 weeks. It was demonstrated that the system 
worked reliably over the whole time. 
One main part of this thesis shows the improvements that were achieved with the 
bioreactor system placing the focus on the mechanical stimulation of tubular 
prostheses. It was shown that several changes to the initial system were required 
to enable a successful imitation of peristaltic stimulation. A kyphoplasty catheter 
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mimicked the physiologic urine drop and a syringe pump inflated and deflated the 
balloon.  
Further experiments lead to an advanced bioreactor design with an improved cell 
culture medium inlet and outlet to eliminate air bubbles inside the bioreactor. 
Moreover, the central fittings became screwable allowing different cell seeding 
mechanisms as well as providing high flexibility with respect to the dimensions and 
material of the applied scaffolds. The Bioreactor Prototype IV is easy to manage 
and it is reusable due to its heat resistance. This makes it ideally suited for 
efficient use in a clinical setup in future. Its suitability is further boosted by the 
possibility to operate at least two bioreactors in parallel (an achievement of this 
study).  
Another achievement was accomplished by restructuring the graphical user 
interface of the system. Visualising current measurement values in numbers in 
combination with diagrams as well as arranging the setting options in tab pages 
lead to a clearly organised graphical user interface. 
The combination of all these elements enabled a mechanical stimulation/training 
with a stretch of 20% and a frequency of 0.015 Hz.  
Efficient cell culture media circuits and a contamination guard developed in this 
study ensured sterile and effective operation Bioreactor Prototype IV. The 
reduction of components achieved by the development of customised screw caps 
for use on the top of the media reservoirs made the use of antibiotics during the 
process dispensable. Sterilisable pH electrodes were introduced into the system to 
enable suitable monitoring of the media condition. Thus, the screw caps 
developed for this study supported the high flexibility of the bioreactor system by 
allowing several monitoring methods.  
Two different biomaterials were tested in combination with various cell types, e.g. 
C2C12 or primary smooth muscle cells. Optimaix 3D Sponge1 was selected 
because of its suitable characteristics shown in first in-vitro and in-vivo studies. 
Nevertheless, it was concluded that this material with its huge wall thickness was 
not applicable in combination with this bioreactor system. Different seeding 
procedures and cultivation under dynamic conditions did not increase cellular 
penetration depth and cellular density, which were required for a mechanical 
stimulation. For that reason, Optimaix 3D Sponge1 was not used for further 
investigations. 
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Fibrin matrices in combination with a stabilising PVDF mesh proved to be 
convenient proper composite materials. Cells were directly casted into their 
position in a homogenous distribution. Incubation periods of 1 week (n=4) and 2 
weeks (n=4) were achieved. Elongated incubation periods require higher amounts 
of Cyklokarpron® to avoid fibrinolysis and failure of the prosthesis. This is based 
on the tPA and uPA producing urothelium of the urinary tract. For that reason, it 
seems reasonable to test other material combinations using e.g. collagen, gelatine 
or alginate. 
Grown tubular constructs were examined with respect to their tightness against 
urine-excreted substances, their mechanical strength, cellular distribution and 
orientation. It became apparent that classical histological analysis could not be 
performed on the Optimaix 3D Sponge1, whereas these methods were useful for 
fibrin-based prostheses. Scanning electron microscopy was useful for both types, 
leading to analysable surface images. LabVIEW-based programs with image 
processing tools revealed preferred directions of cellular orientation subsequent to 
mechanical stimulation. On the outer surface, a thin layer of longitudinally 
arranged cells could be proven, whereas cells inside the fibrin matrix were 
arranged circularly. Even untrained samples showed preferred cellular orientation, 
which might be traced back to the peristaltic perfusion with cell culture medium. 
Nevertheless, the orientation for trained prostheses was significantly increased. It 
can be summarised that two cell layers were detected with different orientations 
that were shifted by 90°, even if this specific setup is more likely to be expected in 
the intestine. Similar observations were not yet found in literature. 
This study was able to show that an Ussing chamber can be used for further 
characterisation of tissue-engineered structures. For this study, the chamber was 
used for monitoring the passive diffusion of urea and creatinine through the tissue 
constructs as well as through native ureters. Similar experiments were shown in 
sed literature and demonstrate that the urothelium plays an important role in the 
diffusion of molecules through the ureters. Results that were achieved in this study 
showed in 5 of 7 (for urea) and 6 of 7 (for creatinine) analysable intraindividual 
experiments that there were differences in passive diffusion based on a 
mechanical stimulation and the use of primary smooth muscle cells. Mechanically 
stressed structures were more permeable for urea and creatinine than untrained 
prostheses. Taken in a whole, the differences were not significant. 
Summary 
 135 
Mechanical strength of the prostheses was determined based on their bursting 
pressures. An automatised measuring setup was developed with a pressure line 
for catheter inflation and deflation and a pressure chamber. Water was 
consistently pressed towards the sample with the syringe pump and generated 
increasing pressure onto the prostheses until they ruptured. Bursting pressures 
were analysed intraindividually and showed in 4 of 6 analysable experiments 
increased bursting pressures for mechanically trained prostheses. A tendency 
which was not yet significant may be observed with respect to the incubation 
periods and mechanical training. It seems that longer incubation periods as well as 
mechanical stress lead to more stable prostheses. 
The novelty and main conclusion of this study is that a mechanical stimulation 
exerted by a catheter in a tubular bioreactor that mimics physiologic conditions 
leads to a bidirectional arrangement of smooth muscle cells. The application and 
mechanical stimulation of primary smooth muscle cells, which were isolated from 
porcine bladder, was intended to be used as ureter replacement. Presented 
results are encouraging to proceed investigations on this system with various 
biomaterial combinations to further enhance the grown tissues to achieve an even 
more physiologic tissue. 
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8 Appendix 
8.1 Abbreviations 
Abbreviation Meaning 
3D Three dimensional 
AAST American association for surgery of trauma 
BSM Bladder submucosa 
BSS Balanced salt solution 
C2C12 Mouse myoblast cell line 
cf. confer 
CO2 Carbon dioxide 
CPD Critical point drying 
DAPI 4′,6-diamidin-2-phenylindol 
di Inner diameter 
DMEM Dulbecco's modified eagle's medium 
e.g. Exempli gratia (for example) 
EAU European association of urology 
ECM Extracellular matrix 
FBS Fetal bovine serum 
GUI Graphical user interface 
HE  Haematoxylin & Eosin 
i.e. id est (meaning) 
ITA Institute for textile technology of the RWTH 
Aachen University 
IZKF Interdisciplinary Centre for Clinical Research 
n Number of data items 
NPS Not part of study 
PBS Phosphate buffered saline 
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Abbreviation Meaning 
PCTFE Polychlortrifluorethylene 
PEEK Polyether ether ketone 
PES Polyethersulfone 
POM Polyoxymethylene 
PPS Polyphenylene sulphide 
PTFE Polytetrafluoroethylene 
PVDF Polyvinylidenfluorid 
ROI Region of interest 
SEM Scanning electron microscope 
SIS Small intestine submucosa 
SMC Smooth muscle cell 
TBS Tris buffered saline 
TE Tissue Engineering 
tPA Tissue-type plasminogen activator 
uPA Urokinase-type plasminogen activator 
UV Ultraviolet 
xi I
th value in the dataset 
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8.2 Medical dictionary 
Term Meaning 
Adventitia Connective tissue layer covering of a hollow organ (e.g. blood 
vessels) for the integration into the surrounding tissue. 
Anastomosis Surgical connection of two separated hollow tubular structures 
(intestine/blood vessel/ureter/urethra) to form a continuous pipe. 
Avulsion Violent tearing off body parts of tissues by accidents or surgery. 
Bilharzial Tropical disease with an infection by schistosomes (small worms), 
leading to the damage of genitourinary tract tissues and other organs. 
Calculus Concentration of mineral salts, forming stones for example in the 
kidney or urinary bladder. 
Caudal Directed/related to the tail. 
Collapse Fall down/break down/cave in of a tissue structure, losing tissue’s 
function. 
Contusion Injury that does not rupture the skin, resulting in a swelling and 
discoloration. 
Cranial Directed/related to the skull.  
Diabetes Chronic disorder of the glucose household. The patient is lacking an 
adequate insulin production, resulting in abnormal concentrations of 
sugar in the blood and urine.  
Endometriosis 
 
Painful periods with abnormal endomaterial tissue that is located 
outside the uterus. 
Fistula Tunnel/passage/duct that connects (abnormal) body cavities and 
hollow organs to other hollow organs or to the body surface. 
Hematoma Damage of a blood vessel resulting a swelling of the tissue due to 
blood inflow. 
Hydronephrosis Distension of the renal pelvis and calyces because of an obstructed 
urinary tract impairing the drainage of urine. 
Iatrogenic 
injury 
Unintentional/undesired injury of patient by a medical intervention. 
Incontinence Uncontrolled/involuntary excretion of urine or fecal matter. 
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Term Meaning 
Intravenous Given/applied into a body’s vein. 
Kyphoplasty Spinal procedure, where a fractured vertebra is reconstructed 
by the injection of bone cement. Vertebrae are inflated in 
balloon kyphoplasty procedures. 
Laceration Irregular/jagged/open wound or cut by for example blunt 
trauma. 
Lamina propria Thin connective tissue layer beneath the epithelium (here: 
urothelium). 
Lumen/luminal Open space/cavity/volume of a hollow organ like blood 
vessels, intestine, ureter or urethra. 
Medial Situated in/directed to the middle. 
Mucosa Membrane lining a hollow organ, excreting mucous. 
Mucous Viscous body secretion produced by moist membranes. 
Myogenically/myogenic Arising from the muscles/myocytes 
Necrosis Dying of cells/tissue due to injury/disease/negative outer 
influences. 
Nephrostomy tube A tube that is placed throughout the skin in the renal pelvis to 
drain the urine.  
Parasagittal  Off/shifted from the medial/sagittal plane that divides the 
body symmetrically into a left and right section. 
Primary injury Injury/trauma of a patient caused by an accident or disease 
or malformation. 
Retrospective Contemplating the past. Looking back on s.th. 
Serosa Serous membrane covering the outer walls of an organ or 
lining body/peritoneal/pleural or pericardial cavities. 
Stent/stenting A tubular mesh that is placed in a tunnel/passage to keep the 
luminal cross section open. Body fluids can be drained. 
Stratum One of several tissue layers that follow one after another in a 
complex organ system. 
Stricture Narrowing of the luminal cross section of a tunnel/passage or 
duct. 
Transection Separation of a tissue by cutting transversally. 
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Term Meaning 
Trauma Serious injury/wound externally caused by accidents or violence. 
Tuberculosis 
 
Infective disease caused by the tubercle bacillus/mycobacterium 
tuberculosis, forming tubercles in the lungs and other tissues. 
Tunica Tissue layer (e.g. muscle) covering other anatomical structures. 
Urinoma A volume/cyst containing urine outside the physiological urine guiding 
system as a result from trauma or obstruction. 
Urogram Radiographic illustration of the urinary tract. 
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8.3 Technical Drawings 
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8.4 Curriculum Vitae 
Der Lebenslauf ist in der Onnline-Version aus Gründen des Datenschutzes nicht 
enthalten. 
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